UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
 
x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended June 28, 2019
or
¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ____ to ____
 
Commission File Number 001-34376
 
IEC ELECTRONICS CORP.
(Exact name of registrant as specified in its charter)
 
Delaware
 
13-3458955
(State or other jurisdiction of
 
(I.R.S. Employer Identification No.)
incorporation or organization)
  
 
 
105 Norton Street, Newark, New York   14513
(Address of Principal Executive Offices) (Zip Code)
  
315-331-7742
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
IEC
NYSE American

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No ¨
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes  x No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ¨
 
Accelerated filer ¨
Non-accelerated filer x
 
Smaller reporting company x
Emerging growth company ¨
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x






Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Common Stock, $0.01 par value – 10,334,583 shares as of August 1, 2019






3



TABLE OF CONTENTS
 
 
 
 

4




Part I     FINANCIAL INFORMATION
 
Item 1.   Condensed Consolidated Financial Statements
 
IEC ELECTRONICS CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
JUNE 28, 2019 and SEPTEMBER 30, 2018
(unaudited; in thousands, except share and per share data)
 
June 28,
2019
 
September 30,
2018
ASSETS
 
 
 
Current assets:
 
 
 
Cash
$

 
$

Accounts receivable, net of allowance
26,612

 
25,168

Unbilled contract revenue
7,305

 

Inventories
44,889

 
34,126

Other current assets
1,893

 
1,747

Total current assets
80,699

 
61,041


 
 
 
Property, plant and equipment, net
19,331

 
20,110

Deferred income taxes
7,999

 
8,855

Other long-term assets
862

 
442

Total assets
$
108,891

 
$
90,448


 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Current portion of long-term debt
$
1,371

 
$
1,449

Current portion of capital lease obligation
331

 
306

Accounts payable
29,510

 
28,689

Accrued payroll and related expenses
3,165

 
1,796

Other accrued expenses
543

 
458

Customer deposits
9,750

 
7,595

Total current liabilities
44,670

 
40,293

 
 
 
 
Long-term debt
26,622

 
16,002

Long-term capital lease obligation
6,772

 
7,027

Other long-term liabilities
1,558

 
1,750

Total liabilities
79,622

 
65,072

Commitments and contingencies (Note 11)
 
 
 
STOCKHOLDERS’ EQUITY
 
 
 
Preferred stock, $0.01 par value:
 
 
 
500,000 shares authorized; none issued or outstanding

 

Common stock, $0.01 par value:
 
 
 
Authorized: 50,000,000 shares
 
 
 
Issued: 11,387,974 and 11,304,393 shares, respectively
 
 
 
Outstanding: 10,332,486 and 10,248,905 shares, respectively
103

 
102

Additional paid-in capital
47,824

 
47,326

Accumulated deficit
(17,069
)
 
(20,463
)
Treasury stock, at cost: 1,055,488 shares
(1,589
)
 
(1,589
)
Total stockholders’ equity
29,269

 
25,376

Total liabilities and stockholders’ equity
$
108,891

 
$
90,448


The accompanying notes are an integral part of these condensed consolidated financial statements.

5



IEC ELECTRONICS CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
THREE and NINE MONTHS ENDED JUNE 28, 2019 and JUNE 29, 2018
(unaudited; in thousands, except share and per share data)
 
Three Months Ended
 
Nine Months Ended
 
June 28,
2019
 
June 29,
2018
 
June 28,
2019
 
June 29,
2018
 
 
 
 
Net sales
$
40,324

 
$
29,782

 
$
113,059

 
$
82,706

Cost of sales
34,719

 
26,423

 
97,808

 
73,045

Gross profit
5,605

 
3,359

 
15,251

 
9,661

 
 
 
 
 
 
 
 
Selling and administrative expenses
3,721

 
2,833

 
10,402

 
8,543

Operating income
1,884

 
526

 
4,849

 
1,118

 
 
 
 
 
 
 
 
Interest and financing expense
452

 
322

 
1,160

 
834

Income before income taxes
1,432

 
204

 
3,689

 
284

 
 
 
 
 
 
 
 
Income tax expense/(benefit)
221

 

 
736

 
(1,005
)
 
 
 
 
 
 
 
 
Net income
$
1,211

 
$
204

 
$
2,953

 
$
1,289

 
 
 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
 
 
Basic
$
0.12

 
$
0.02

 
$
0.28

 
$
0.12

Diluted
$
0.11

 
$
0.02

 
$
0.28

 
$
0.12

 
 
 
 
 
 
 
 
Weighted average number of shares outstanding:
 
 
 
 
 
 
Basic
10,332,548

 
10,243,286

 
10,294,173

 
10,221,869

Diluted
10,642,403

 
10,556,764

 
10,556,953

 
10,467,112

 
The accompanying notes are an integral part of these condensed consolidated financial statements.

6




IEC ELECTRONICS CORP.
CONDENSED CONSOLIDATED STATEMENT of CHANGES in STOCKHOLDERS’ EQUITY
NINE MONTHS ENDED JUNE 28, 2019
(unaudited; in thousands, except share data)

 
 
Number of Shares Outstanding

 
Common
Stock,
par $0.01

 
Additional
Paid-In
Capital

 
Accumulated Deficit

 
Treasury
Stock,
at cost

 
Total
Stockholders’
Equity

Balances, October 1, 2018
 
10,248,905

 
$
102

 
$
47,326

 
$
(20,463
)
 
$
(1,589
)
 
$
25,376

 
 
 
 
 
 
 
 
 
 
 
 
 
Impact of adoption of ASC 606, net of taxes
 

 

 

 
441

 

 
441

Net income
 

 

 

 
1,072

 

 
1,072

Stock-based compensation
 

 

 
146

 
 
 

 
146

Restricted stock vested, net of shares withheld for payment of taxes
 
4,439

 

 

 

 

 

Exercise of stock options, net of shares surrendered
 
2,553

 

 

 

 

 

Employee stock plan purchases
 
5,674

 

 
20

 

 

 
20

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, December 28, 2018
 
10,261,571

 
102

 
47,492

 
(18,950
)
 
(1,589
)
 
27,055

 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 

 

 

 
670

 

 
670

Stock-based compensation
 

 

 
152

 
 
 

 
152

Restricted stock vested, net of shares withheld for payment of taxes
 
38,636

 
1

 

 

 

 
1

Exercise of stock options, net of shares surrendered
 
11,654

 

 
51

 

 

 
51

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, March 29, 2019
 
10,311,861

 
103

 
47,695

 
(18,280
)
 
(1,589
)
 
27,929

 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 

 

 

 
1,211

 

 
1,211

Stock-based compensation
 

 

 
117

 

 

 
117

Restricted stock vested, net of shares withheld for payment of taxes
 
2,458

 

 
(14
)
 

 

 
(14
)
Restricted stock units vested, net of shares withheld for payment of taxes
 
5,277

 

 
(34
)
 

 

 
(34
)
Exercise of stock options, net of shares surrendered
 
7,500

 

 
27

 

 

 
27

Employee stock plan purchases
 
5,390

 

 
33

 

 

 
33

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, June 28, 2019
 
10,332,486

 
$
103

 
$
47,824

 
$
(17,069
)
 
$
(1,589
)
 
$
29,269


The accompanying notes are an integral part of these condensed consolidated financial statements.


7




IEC ELECTRONICS CORP.
CONDENSED CONSOLIDATED STATEMENT of CHANGES in STOCKHOLDERS’ EQUITY
NINE MONTHS ENDED JUNE 29, 2018
(unaudited; in thousands, except share data)

 
 
Number of Shares Outstanding

 
Common
Stock,
par $0.01

 
Additional
Paid-In
Capital

 
Accumulated Deficit

 
Treasury
Stock,
at cost

 
Total
Stockholders’
Equity

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, October 1, 2017
 
10,197,078

 
$
102

 
$
46,789

 
$
(30,873
)
 
$
(1,589
)
 
$
14,429

 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
 

 

 

 
(494
)
 

 
(494
)
Stock-based compensation
 

 

 
69

 

 

 
69

Restricted stock vested, net of shares withheld for payment of taxes
 
3,498

 

 

 

 

 

Employee stock plan purchases
 
5,483

 

 
24

 

 

 
24

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, December 29, 2017
 
10,206,059

 
102

 
46,882

 
(31,367
)
 
(1,589
)
 
14,028

 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 

 

 

 
1,579

 

 
1,579

Stock-based compensation
 

 

 
129

 

 

 
129

Restricted stock vested, net of shares withheld for payment of taxes
 
30,530

 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, March 30, 2018
 
10,236,589

 
102

 
47,011

 
(29,788
)
 
(1,589
)
 
15,736

 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 

 

 

 
204

 

 
204

Stock-based compensation
 

 

 
149

 

 

 
149

Restricted stock vested, net of shares withheld for payment of taxes
 
3,529

 

 

 

 

 

Exercise of stock options
 
1,400

 

 

 

 

 

Employee stock plan purchases
 
6,565

 

 
26

 

 

 
26

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, June 29, 2018
 
10,248,083

 
$
102

 
$
47,186

 
$
(29,584
)
 
$
(1,589
)
 
$
16,115

 
The accompanying notes are an integral part of these condensed consolidated financial statements.

8



IEC ELECTRONICS CORP.
CONDENSED CONSOLIDATED STATEMENTS of CASH FLOWS
NINE MONTHS ENDED JUNE 28, 2019 and JUNE 29, 2018
(unaudited; in thousands)  
 
 
Nine Months Ended
 
 
June 28,
2019
 
June 29,
2018
 
 
 
 

CASH FLOWS FROM OPERATING ACTIVITIES
 
 
 
 
Net income
 
$
2,953

 
$
1,289

Non-cash adjustments:
 
 
 
 
Stock-based compensation
 
415

 
347

Depreciation and amortization
 
2,047

 
1,708

Change in reserve for doubtful accounts
 
(30
)
 
(42
)
Change in inventory reserve and warranty reserve
 
19

 
143

Deferred tax expense/(benefit)
 
732

 
(1,010
)
Amortization of deferred gain
 
(85
)
 
(54
)
Changes in assets and liabilities:
 
 
 
 
Accounts receivable
 
(1,414
)
 
(1,739
)
Unbilled contract revenue
 
(2,972
)
 

Inventory
 
(14,485
)
 
(10,612
)
Other current assets
 
(146
)
 
(204
)
Other long-term assets
 
(436
)
 
4

Accounts payable
 
1,293

 
3,268

Change in book overdraft position
 
(602
)
 
1,268

Accrued expenses
 
1,389

 
1,171

Customer deposits
 
2,155

 
790

Other long-term liabilities
 
(75
)
 
(75
)
Net cash flows used in operating activities
 
(9,242
)
 
(3,748
)
 
 
 
 
 
CASH FLOWS FROM INVESTING ACTIVITIES
 
 
 
 
Purchases of property, plant and equipment
 
(1,119
)
 
(2,001
)
Proceeds from disposal of property, plant and equipment
 
20

 
5

Proceeds from sale-leaseback
 

 
1,947

Net cash flows used in investing activities
 
(1,099
)
 
(49
)
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES
 
 
 
 
Advances from revolving credit facility
 
57,343

 
47,402

Repayments of revolving credit facility
 
(46,331
)
 
(41,609
)
Borrowings under other loan agreements
 
391

 
836

Repayments under other loan agreements
 
(889
)
 
(2,665
)
Repayments under capital lease
 
(230
)
 
(172
)
Debt issuance costs
 
(27
)
 
(45
)
Proceeds from exercise of stock options
 
79

 

Proceeds from employee stock plan purchases
 
53

 
50

Cash paid for taxes upon vesting of restricted stock
 
(48
)
 

Net cash flows provided by financing activities
 
10,341

 
3,797

 
 
 
 
 
Net cash change for the period
 

 

Cash, beginning of period
 

 

Cash, end of period
 
$

 
$

 
 
 
 
 
Supplemental cash flow information
 
 
 
 
Interest paid
 
$
1,183

 
$
807

Income taxes paid
 
3

 
4

Property, plant and equipment additions financed through capital lease
 

 
2,000

 
 
 
 
 
Non-cash transactions:
 
 
 
 
Property, plant and equipment purchased with extended payment terms
 
$
130

 
$

The accompanying notes are an integral part of these condensed consolidated financial statements.

9



IEC ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
 
NOTE 1—OUR BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Our Business
 
IEC Electronics Corp. (“IEC,” or the “Company”) provides electronic manufacturing services (“EMS”) to advanced technology companies that produce life-saving and mission critical products for the medical, industrial, aerospace and defense sectors. The Company specializes in delivering technical solutions for the custom manufacture of complex full system assemblies by providing on-site analytical testing laboratories, custom design and test engineering services combined with a broad array of manufacturing services encompassing electronics, interconnect solutions, and precision metalworking.  As a full service EMS provider, IEC holds all appropriate certifications for the market sectors it supports including ISO 9001:2008, AS9100C, and ISO 13485, and we are Nadcap accredited.  IEC is headquartered in Newark, NY and also has operations in Rochester, NY and Albuquerque, NM.  Additional information about IEC can be found on its web site at www.iec-electronics.com . The contents of this website are not incorporated by reference into this quarterly report.
 
Generally Accepted Accounting Principles
 
IEC’s financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”).
 
Fiscal Calendar
 
The Company’s fiscal year ends on September 30th and the first three quarters generally end on the Friday closest to the last day of the calendar quarter. For the fiscal year ending September 30, 2019 (“fiscal 2019 ”), the fiscal quarters ended on December 28, 2018 , March 29, 2019 and June 28, 2019 . For the fiscal year ended September 30, 2018 (“fiscal 2018 ”), the fiscal quarters ended on December 29, 2017 , March 30, 2018 and June 29, 2018 .
 
Consolidation
 
The condensed consolidated financial statements include the accounts of IEC and its wholly-owned subsidiaries: IEC Electronics Corp-Albuquerque (“Albuquerque”); IEC Analysis & Testing Laboratory, LLC (“ATL”); and IEC California Holdings, Inc. The Rochester unit operates as a division of IEC. All intercompany transactions and accounts are eliminated in consolidation. 

Unaudited Financial Statements
 
The accompanying unaudited condensed consolidated financial statements for the three and nine months ended June 28, 2019 and June 29, 2018 have been prepared without an audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and do not include certain of the information the footnotes require by GAAP for complete financial statements.  In the opinion of management, all adjustments, consisting of normal recurring adjustments, required for a fair presentation of the information have been made.  The accompanying financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018 .
   
Cash
 
The Company’s cash represents deposit accounts with Manufacturers and Traders Trust Company (“M&T Bank”), a banking corporation headquartered in Buffalo, NY. The Company’s cash management system provides for the funding of the disbursement accounts on a daily basis as checks are presented for payment. Under this system, outstanding checks in excess of the bank balance create a book overdraft. Book overdrafts are presented in accounts payable in the condensed consolidated balance sheets. Book overdrafts were $2.0 million and $2.6 million as of June 28, 2019 and September 30, 2018 , respectively. Changes in the book overdrafts are presented within net cash flows provided by operating activities within the condensed consolidated statements of cash flows.
 

10



Allowance for Doubtful Accounts
 
The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability.  Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that the likelihood of collection is remote.
 
Inventory Valuation
 
Inventories are stated at the lower of cost or net realizable value under the first-in, first-out method.  The Company regularly assesses slow-moving, excess and obsolete inventory and maintains balance sheet reserves in amounts required to reduce the recorded value of inventory to the lower of cost or net realizable value.
 
Property, Plant and Equipment
 
Property, plant and equipment (“PP&E”) are stated at cost and are depreciated over various estimated useful lives using the straight-line method.  Maintenance and repairs are charged to expense as incurred, while renewals and improvements are capitalized.  At the time of retirement or other disposition of PP&E, cost and accumulated depreciation are removed from the accounts and any gain or loss is recorded in earnings.
 
Depreciable lives generally used for PP&E are presented in the table below.  Leasehold improvements are amortized over the shorter of the lease term or estimated useful life of the improvement.
PP&E Lives
 
Estimated
Useful Lives
 
 
(years)
Land improvements
 
10
Buildings and improvements
 
5 to 40
Machinery and equipment
 
3 to 5
Furniture and fixtures
 
3 to 7
Software
 
3 to 10
   
Reviewing Long-Lived Assets for Potential Impairment
 
ASC 360 (Property, Plant and Equipment) requires the Company to test long-lived assets (PP&E and definite lived assets) for recoverability whenever events or circumstances indicate that the carrying amount may not be recoverable.  If carrying value exceeds undiscounted future cash flows attributable to an asset, it is considered impaired and the excess of carrying value over fair value must be charged to earnings.  No impairment charges were recorded by IEC for long-lived assets during either of the three or nine months ended June 28, 2019 and June 29, 2018 .
 
Leases
 
At the inception of a lease covering equipment or real estate, the lease agreement is evaluated under criteria discussed in ASC 840 (Leases).  Leases meeting one of four key criteria are accounted for as capital leases and all others are treated as operating leases.  Under a capital lease, the discounted value of future lease payments becomes the basis for recognizing an asset and a borrowing, and lease payments are allocated between debt reduction and interest.  For operating leases, payments are recorded as rent expense.  Criteria for a capital lease include (i) transfer of ownership during the lease term; (ii) existence of a bargain purchase option under terms that make it likely to be exercised; (iii) a lease term equal to 75 percent or more of the economic life of the leased property; and (iv) minimum lease payments that equal or exceed 90 percent of the fair value of the property.

Legal Contingencies
 
When legal proceedings are brought or claims are made against the Company and the outcome is uncertain, ASC 450 (Contingencies) requires the Company to determine whether it is probable that an asset has been impaired or a liability has been incurred.  If such impairment or liability is probable and the amount of loss can be reasonably estimated, the loss must be charged to earnings. 
 
When it is considered probable that a loss has been incurred but the amount of loss cannot be estimated, disclosure but not accrual of the probable loss is required.  Disclosure of a loss contingency is also required when it is reasonably possible, but not probable, that a loss has been incurred. 


11



Legal Expense Accrual

The Company records legal expenses as they are incurred, based on invoices received or estimates provided by legal counsel. Future estimated legal expenses are not recorded until incurred.

Customer Deposits

Customer deposits represent amounts invoiced to customers for which the revenue has not yet been earned and therefore represent a commitment for the Company to deliver goods or services in the future. Deposits are generally short term in nature and are recognized as revenue when earned.
 
Fair Value Measurements
 
Under ASC 825 (Financial Instruments), the Company is required to disclose the fair value of financial instruments for which it is practicable to estimate value.  The Company’s financial instruments consist of cash, accounts receivable, accounts payable, accrued liabilities and borrowings.  IEC believes that recorded value approximates fair value for all cash, accounts receivable, accounts payable, accrued liabilities and borrowings.
 
ASC 820 (Fair Value Measurements and Disclosures) defines fair value, establishes a framework for measurement, and prescribes related disclosures.  ASC 820 defines fair value as the price that would be received upon sale of an asset or would be paid to transfer a liability in an orderly transaction.  Inputs used to measure fair value are categorized under the following hierarchy:
 
Level 1: Quoted prices in active markets for identical assets or liabilities that the Company can access at the measurement date.
 
Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable market data.
 
Level 3: Model-derived valuations in which one or more significant inputs are unobservable.
 
The Company deems a transfer between levels of the fair value hierarchy to have occurred at the beginning of the reporting period.  There were no such transfers during each of the three and nine months ended June 28, 2019 and June 29, 2018 .

Stock-Based Compensation
 
ASC 718 (Stock Compensation) requires that compensation expense be recognized for equity awards based on fair value as of the date of grant.  For stock options, the Company uses the Black-Scholes pricing model to estimate grant date fair value.  Costs associated with stock awards are recorded over requisite service periods, generally the vesting period.  If vesting is contingent on the achievement of performance objectives, fair value is accrued over the period the objectives are expected to be achieved only if it is considered probable that the objectives will be achieved.  The Company also has an employee stock purchase plan (“ESPP”) that provides for the purchase of Company common stock at a discounted stock purchase price.

Income Taxes and Deferred Taxes
 
ASC 740 (Income Taxes) requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns, but not in both.  Deferred tax assets are also established for tax benefits associated with tax loss and tax credit carryforwards.  Such deferred tax balances reflect tax rates that are scheduled to be in effect, based on currently enacted legislation, in the years the book/tax differences reverse and tax loss and tax credit carryforwards are expected to be realized.  An allowance is established for any deferred tax asset for which realization is not likely.
 
ASC 740 also prescribes the manner in which a company measures, recognizes, presents and discloses in its financial statements uncertain tax positions that the company has taken or expects to take on a tax return.  The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the position will be sustained following examination by taxing authorities, based on technical merits of the position.  The Company believes that it has no material uncertain tax positions.
 

12



Any interest incurred is reported as interest expense. Any penalties incurred are reported as tax expense. The Company’s income tax filings are subject to audit by various tax jurisdictions and current open years are the fiscal year ended September 30, 2014 through fiscal year ended September 30, 2018.
 
Dividends
 
IEC does not pay dividends on its common stock as it is the Company’s current policy to retain earnings for use in the business.  Furthermore, the Company’s Fifth Amended and Restated Credit Facility Agreement, as amended, with M&T Bank includes certain restrictions on paying cash dividends, as more fully described in Note 6—Credit Facilities

Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent assets and liabilities. Significant items subject to such estimates include: allowance for doubtful accounts, excess and obsolete inventory reserve, warranty reserves, the valuation of deferred income tax assets and revenue recognition related to the accounts for over time contracts. Actual results may differ from management’s estimates.
 
Statements of Cash Flows
 
The Company presents operating cash flows using the indirect method of reporting under which non-cash income and expense items are removed from net income. 

Segments

The Company’s results of operations for the three and nine months ended June 28, 2019 and June 29, 2018 represent a single operating and reporting segment, referred to as contract manufacturing within the EMS industry. The Company strategically directs production between its various manufacturing facilities based on a number of considerations to best meet its customers’ requirements. The Company shares resources for sales, marketing, engineering, supply chain, information services, human resources, payroll and corporate accounting functions. Consolidated financial information is available that is evaluated regularly by the chief operating decision maker in assessing performance and allocating resources.  The Company’s operations as a whole reflect the level at which the business is managed and how the Company’s chief operating decision maker assesses performance internally.
 
Recently Issued Accounting Standards Adopted
 
FASB Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers” (“ASC 606”) was issued in May 2014 and updated the principles for recognizing revenue. This ASU superseded most of the existing revenue recognition requirements in GAAP. Under the new standard, revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. The standard creates a five-step model that generally requires companies to use more judgment and make more estimates than under previous guidance when considering the terms of contracts along with all relevant facts and circumstances. These include the identification of customer contracts and separating performance obligations, the determination of the transaction price that potentially includes an estimate of variable consideration, allocating the transaction price to each separate performance obligation, and recognizing revenue in line with the pattern of transfer. Additionally, disclosures required for revenue recognition include qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments, and assets recognized from costs to obtain or fulfill a contract. Such disclosures are more extensive than what was required under previous GAAP.

The guidance was effective for the Company beginning with the first quarter of fiscal 2019. The Company evaluated the guidance and approved a transition method during fiscal 2018. The Company assessed the impact of the new guidance, which resulted in a change of the Company’s revenue recognition model for electronics manufacturing services from “point in time” upon physical delivery to an “over time” model. The Company implemented ASC 606 using the modified retrospective approach with the cumulative effect on accumulated deficit on adoption of $0.4 million , net of taxes recognized on October 1, 2018. The implementation of ASC 606 is more fully described in Note 2—Revenue Recognition .

Recently Issued Accounting Standards Not Yet Adopted

FASB ASU 2016-02, “Leases” (Topic 842) was issued in February 2016. This update supersedes ASC 840 (Leases) and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the

13



principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease for finance leases and operating leases, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. In July 2018, the FASB issued ASU 2018-10, “Codification Improvements to Topic 842 (Leases),” and ASU 2018-11, “Leases (Topic 842),” Targeted Improvements, which provide (i) narrow amendments to clarify how to apply certain aspects of the new lease standard, (ii) entities with an additional transition method to adopt the new standard, and (iii) lessors with a practical expedient for separating components of a contract. In December 2018, the FASB issued ASU 2018-20, “Leases (Topic 842): Narrow-Scope Improvements for Lessors,” which provides certain narrow-scope improvements to Topic 842 as it relates to lessors. The ASUs related to Topic 842 will be effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is in the process of finalizing the analysis of its lease portfolio, implementing systems and processes and updating its accounting policies to comply with Topic 842.

NOTE 2—REVENUE RECOGNITION

ASC 606: Revenue from Contracts with Customers

General Description of the New Guidance
 
Effective October 1, 2018, the Company applied the modified retrospective approach for its adoption of ASC 606. The primary impact of the new standard resulted in a change in the timing of the Company’s revenue recognition for some customer contracts for our custom manufacturing services to recognizing revenue over time as products are manufactured, as opposed to the prior revenue recognition of point in time. The transitional adjustment resulted in the recognition of unbilled revenue with a corresponding reduction in finished goods and work-in-process inventory (“WIP inventory”). The Company recognized the cumulative effect of initially applying the new revenue standard, totaling $0.4 million , net of tax, as an adjustment to its opening accumulated deficit balance at October 1, 2018 included in stockholders’ equity. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.
 
Satisfaction of Performance Obligations
 
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in ASC 606. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Many of the Company's contracts have a single performance obligation as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts and, therefore, not distinct. The Company primarily provides contract manufacturing services to its customers. The customer provides a design, the Company procures materials and manufactures to that design and ships the product to the customer. Revenue is derived primarily from the manufacturing of these electronics components that are built to customer specifications.

The Company's performance obligations are satisfied at a point in time or over time as work progresses. Revenue from goods and services transferred to customers at a point in time accounted for 52.3% and 50.8% of the Company's revenue for the three and nine months ended June 28, 2019 , respectively. Revenue on these contracts is recognized when obligations under the terms of the customer contract are satisfied; generally this occurs with the transfer of control upon shipment. If there is no enforceable right to payment for work completed to date, or the Company does not recapture costs incurred plus an applicable margin, then the Company records revenue upon shipment to the customer.

Revenue from goods and services transferred to customers over time accounted for 47.7% and 49.2% of our revenue for the three and nine months ended June 28, 2019 , respectively. For revenue recognized over time, the Company uses an input measure to determine progress towards completion. Under this method, sales and gross profit are recognized as work is performed generally based on the relationship between the actual costs incurred and the total estimated costs at completion. If the Company has an enforceable right to payment for work completed to date, with a recapture of costs incurred plus an applicable margin, and the goods do not have an alternative future use once the manufacturing process has commenced, then the Company records an unbilled revenue associated with non-cancellable customer orders.

The Company derives revenue from engineering and design services. Service revenue is generally recognized once the service has been rendered.  For material management arrangements, revenue is generally recognized as services are rendered.  Under such arrangements, some or all of the following services may be provided: design, bid, procurement, testing, storage or other activities relating to materials the customer expects to incorporate into products that it manufactures.  Value-added support services revenue, including material management and repair work revenue, amounted to less than 3% of total revenue in each of the three and nine months ended June 28, 2019 and June 29, 2018 .

14



 
Returns and Discounts

The Company does not offer its customers a right of return. Rather, the Company warrants that each unit received by the customer will meet the agreed upon technical and quality specifications and requirements. Only when the delivered units do not meet these requirements can the customer return the non-compliant units as a corrective action under the warranty. The remedy offered to the customer is repair of the returned units or replacement if repair is not viable. Accordingly, the Company records a warranty reserve and any warranty activities are not considered to be a separate performance obligation. Historically, warranty reserves have not been material.

Provisions for discounts, allowances, estimated returns and other adjustments are recorded in the period the related sales are recognized.

Shipping and Handling Costs

Amounts billed to customers for shipping and handling activities after the customer obtains control are treated as a promised service performance obligation and recorded in net sales in the accompanying condensed consolidated statements of operations. Shipping and handling costs incurred by the Company for the delivery of goods to customers are considered a cost to fulfill the contract and are included in cost of sales in the accompanying condensed consolidated statements of operations.

Contract Assets

Contract assets consist of unbilled contract amounts resulting from sales under contracts when the revenue recognized exceeds the amount billed to the customer.

Practical Expedients and Exemptions

The Company generally expenses incremental costs of obtaining a contract when incurred because the amortization period would be less than one year. These costs primarily relate to sales commissions and are recorded in selling and administrative expense in the condensed consolidated statements of operations.

The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

Disaggregated Revenue

The table below shows net sales from contracts with customers by market sector. See additional information regarding market sectors in Note 10—Market Sectors and Major Customers .
 
 
Three Months Ended
 
Nine Months Ended
 
 
June 28, 2019
 
June 28, 2019
 
 
Point in Time
 
Over Time
 
Net Sales
 
Point in Time
 
Over Time
 
Net Sales
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Aerospace & Defense
 
$
11,300

 
$
13,298

 
$
24,598

 
$
30,950

 
$
35,755

 
$
66,705

Medical
 
5,127

 
3,744

 
8,871

 
12,441

 
12,432

 
24,873

Industrial
 
4,657

 
2,198

 
6,855

 
14,063

 
7,418

 
21,481

 
 
$
21,084

 
$
19,240

 
$
40,324

 
$
57,454

 
$
55,605

 
$
113,059



15



Impact of adoption of ASC 606

The following table presents the impacted financial statement line items in the condensed consolidated balance sheet as of October 1, 2018: 
 
 
 Balances Without Adoption of ASC 606
 
 Effect of Change
 
Adjusted
(in thousands)
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Unbilled contract revenue
 
$

 
$
4,333

 
$
4,333

Inventories
 
34,126

 
(3,768
)
 
30,358

Deferred income taxes
 
8,855

 
(124
)
 
8,731

 
 
 
 
 
 
 
Stockholders’ Equity:
 
 
 
 
 
 
Accumulated deficit
 
(20,463
)
 
441

 
(20,022
)

The following table presents the impacted financial statement line items in the condensed consolidated balance sheet as of June 28, 2019
 
 
 Balances Without Adoption of ASC 606
 
 Effect of Change
 
 As Reported
(in thousands)
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Unbilled contract revenue
 
$

 
$
7,305

 
$
7,305

Inventories
 
51,086

 
(6,197
)
 
44,889

Deferred income taxes
 
8,242

 
(243
)
 
7,999

 
 
 
 
 
 
 
Stockholders’ Equity:
 
 
 
 
 
 
Accumulated deficit
 
(17,934
)
 
865

 
(17,069
)
 
The following table presents the impacted financial statement line items under ASC 605 "Revenue Recognition" and ASC 606 in the condensed consolidated statements of operations for the three and nine months ended June 28, 2019 :  
 
 
Three Months Ended
 
Nine Months Ended
 
 
June 28, 2019
 
June 28, 2019
 
 
 Balances
Without
Adoption of
ASC 606
 
 Effect
of
Change
 
 As Reported
 
 Balances
Without
Adoption of
ASC 606
 
 Effect
of
Change
 
 As Reported
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
39,062

 
$
1,262

 
$
40,324

 
$
110,087

 
$
2,972

 
$
113,059

Cost of sales
 
33,604

 
1,115

 
34,719

 
95,379

 
2,429

 
97,808

Gross profit
 
5,458

 
147

 
5,605

 
14,708

 
543

 
15,251

Income tax expense
 
189

 
32

 
221

 
617

 
119

 
736

Net income
 
1,096

 
115

 
1,211

 
2,529

 
424

 
2,953


For each of the three and nine months ended June 28, 2019 and June 29, 2018, less than 1% of net sales were shipped to locations outside the United States.


16



NOTE 3—ALLOWANCE FOR DOUBTFUL ACCOUNTS

A summary follows of activity in the allowance for doubtful accounts during the nine months ended June 28, 2019 and June 29, 2018 :
 
 
Nine Months Ended
Allowance for doubtful accounts
 
June 28,
2019
 
June 29,
2018
(in thousands)
 
 
 
 
Allowance, beginning of period
 
$
85

 
$
75

Change in provision for doubtful accounts
 
(30
)
 
(42
)
Write-offs
 

 

Allowance, end of period
 
$
55

 
$
33

 
NOTE 4—INVENTORIES  

A summary of inventory by category at period end follows:
Inventories

June 28,
2019

September 30,
2018
(in thousands)

 



Raw materials
 
$
28,737

 
$
21,323

Work-in-process
 
12,793

 
11,263

Finished goods
 
3,359

 
1,540

Total inventories
 
$
44,889

 
$
34,126


NOTE 5—PROPERTY, PLANT AND EQUIPMENT, NET  

A summary of property, plant and equipment and accumulated depreciation at period end follows:
Property, Plant and Equipment
 
June 28,
2019
 
September 30,
2018
(in thousands)
 
 
 
 
Land and improvements
 
$
788

 
$
788

Buildings and improvements
 
7,397

 
7,314

Building under capital lease
 
7,750

 
7,750

Machinery and equipment
 
31,593

 
30,969

Furniture and fixtures
 
7,923

 
7,877

Software
 
5,215

 

Construction in progress
 
557

 
5,360

Total property, plant and equipment, at cost
 
61,223

 
60,058

Accumulated depreciation
 
(41,892
)
 
(39,948
)
Property, plant and equipment, net
 
$
19,331

 
$
20,110

 
Depreciation expense during the three and nine months ended June 28, 2019 and June 29, 2018 follows:
 
 
Three Months Ended
 
Nine Months Ended

 
June 28,
2019
 
June 29,
2018
 
June 28,
2019
 
June 29,
2018
(in thousands)
 
 
 
 
 
 
 
 
Depreciation expense
 
$
707

 
$
567

 
$
2,008

 
$
1,729



17



NOTE 6—CREDIT FACILITIES  

A summary of borrowings at period end follows:   
 
 

 
 
 
June 28, 2019
 
September 30, 2018
Debt
 
Fixed/Variable Rate
 
Maturity Date
 
Balance
 
Interest Rate
 
Balance
 
Interest Rate
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
M&T Bank credit facilities:
 
 
 
 
 
 
 
 
 
 
 
 
Revolving Credit Facility
 
v
 
5/5/2022
 
$
24,008

 
4.94
%
 
$
12,996

 
5.26
%
Term Loan B
 
v
 
5/5/2022
 
2,993

 
5.19

 
3,636

 
5.36

Equipment Line Advances
 
v
 
Various
 

 

 
314

 
5.56

Equipment Line Term Note
 
v
 
Various
 
1,254

 
5.28

 
794

 
5.56

Total debt, gross
 
 
 
 
 
28,255

 
 
 
17,740

 
 
Unamortized debt issuance costs
 
 
 
 
 
(262
)
 
 
 
(289
)
 
 
Total debt, net
 
 
 
 
 
27,993

 
 
 
17,451

 
 
Less: current portion
 
 
 
 
 
(1,371
)
 
 
 
(1,449
)
 
 
Long-term debt
 
 
 
 
 
$
26,622

 
 
 
$
16,002

 
 

M&T Bank Credit Facilities

During the quarter ended March 29, 2019, the Company and M&T Bank entered into the Seventh and Eighth Amendments to the Fifth Amended and Restated Credit Facility Agreement, which amended the Fifth Amended and Restated Credit Facility Agreement dated as of December 14, 2015, as amended by various amendments (collectively, the “Credit Facility, as amended”). Among other things, the Seventh Amendment increased the Company’s revolving credit commitment to $27.0 and added a monthly information requirement for backlog conversion ratio metrics. The Eighth Amendment modified the definition of “Borrowing Base” to increase the amount of certain availability limits contained within the definition.

The Credit Facility, as amended, is secured by a general security agreement covering the assets of the Company and its subsidiaries, a pledge of the Company’s equity interest in its subsidiaries, a negative pledge on the Company’s real property, and a guarantee by the Company’s subsidiaries, all of which restrict use of these assets to support other financial instruments.

Individual debt facilities provided under the Credit Facility, as amended, are described below:

a)
Revolving Credit Facility (“Revolver”) : At June 28, 2019 , up to $27.0 million is available through May 5, 2022 . The maximum amount the Company may borrow is determined based on a borrowing base calculation described below.
b)
Term Loan B: $14.0 million was borrowed on January 18, 2013. Principal was being repaid in 120 equal monthly installments of $117 thousand . As part of an amendment to the Credit Facility, as amended, the principal was modified from $8.0 million to $6.0 million and principal is being repaid in equal monthly installments of $71 thousand plus a balloon payment of $0.6 million . The maturity date of the loan is May 5, 2022 .
c)
Equipment Line Advances : Up to $1.5 million is available through May 5, 2022 . Interest only is paid until maturity. Principal is due in three or six months after borrowing or can be converted to an Equipment Line Term Loan. On September 18, 2018, $0.3 million was borrowed and upon maturity at March 18, 2019, was converted into an Equipment Line Term Loan. On November 6, 2018 , an additional $0.4 million was borrowed and upon maturity at May 6, 2019, was converted into an Equipment Line Term Note.
d)
Equipment Line Term Note : On July 26, 2018, $0.8 million was converted from an Equipment Line Advance, principal is being repaid in 36 equal monthly installments of $21 thousand and matures July 26, 2021. On September 27, 2018, $0.1 million was converted from an Equipment Line Advance, principal is being repaid in 36 equal monthly installments of $2 thousand and matures September 29, 2021. On March 18, 2019, $0.3 million was converted from an Equipment Line Advance, principal is being repaid in 36 equal monthly installments of $9 thousand and matures March 18, 2022. On May 6, 2019, $0.4 million was converted from an Equipment Line Advance, principal is being repaid in 36 equal monthly installments of $11 thousand and matures May 6, 2022.



18



Borrowing Base

At June 28, 2019 , under the Credit Facility, as amended, the maximum amount the Company can borrow under the Revolver was the lesser of (i) 85% of eligible receivables plus a percentage of eligible inventories (up to a cap of $14.0 million ) or (ii) $27.0 million . At September 30, 2018 , under the Credit Facility, as amended, the maximum amount the Company can borrow under the Revolver was the lesser of (i) 85% of eligible receivables plus a percentage of eligible inventories (up to a cap of $8.0 million ) or (ii) $22.0 million .

At June 28, 2019 , the upper limit on Revolver borrowings was $27.0 million with $3.0 million available. At September 30, 2018 , the upper limit on Revolver borrowings was $22.0 million with $9.0 million available. Average Revolver balances amounted to $20.0 million and $11.8 million during the nine months ended June 28, 2019 and June 29, 2018 , respectively.

Interest Rates

Under the Credit Facility, as amended, variable rate debt accrues interest at LIBOR plus the applicable marginal interest rate that fluctuates based on the Company’s Fixed Charge Coverage Ratio, as defined below. At June 28, 2019 , the applicable marginal interest rate was 2.50% for the Revolver and 2.75% for Term Loan B and Equipment Line Advances . At September 30, 2018 , the applicable marginal interest rate was 3.00% for the Revolver and 3.25% for Term Loan B and Equipment Line Advances . Changes to applicable margins and unused fees resulting from the Fixed Charge Coverage Ratio generally become effective mid-way through the subsequent quarter.

The Company incurs quarterly unused commitment fees ranging from 0.25% to 0.375% of the excess of $27.0 million over average borrowings under the Revolver. Fees incurred amounted to $2.6 thousand and $15.3 thousand during the three and nine months ended June 28, 2019 , respectively. Fees incurred amounted to $5.3 thousand and $16.5 thousand during the three and nine months ended June 29, 2018 , respectively. The fee percentage varies based on the Company’s Fixed Charge Coverage Ratio, as defined below.

Financial Covenants

The Credit Facility, as amended, contains various affirmative and negative covenants including financial covenants. As of June 28, 2019 , the Company had to maintain a minimum fixed charge coverage ratio (“Fixed Charge Coverage Ratio”). The Fixed Charge Coverage Ratio compares (i) EBITDAS minus unfinanced capital expenditures minus income tax expense, to (ii) the sum of interest expense, principal payments, payments on all capital lease obligations and dividends, if any (fixed charges). “EBITDAS” is defined as earnings before interest, income taxes, depreciation, amortization and non-cash stock compensation expense. The Fixed Charge Coverage Ratio was measured for a trailing twelve months ended June 28, 2019 as a minimum of 1.10 times. The Fixed Charge Coverage Ratio was the only covenant in effect at June 28, 2019 . The Credit Facility, as amended, also provides for customary events of default, subject in certain cases to customary cure periods, in which the outstanding balance and any unpaid interest would become due and payable.

The Company was in compliance with the financial debt covenant at June 28, 2019 .

Contractual Principal Payments

A summary of contractual principal payments under IEC’s borrowings at June 28, 2019 for the next three years taking into consideration the Credit Facility, as amended, is as follows:
Debt Repayment Schedule
 
Contractual
Principal
Payments
(in thousands)
 
 

Twelve months ending June
 
 

2020

 
$
1,371

2021

 
1,371

2022
(1)  
 
25,513

 
 
 
$
28,255

(1) Includes Revolver balance of $24.0 million at June 28, 2019 .

As more fully described in Note 14—Subsequent Events , effective as of July 8, 2019, the Company and M&T Bank entered into the Ninth Amendment to Fifth Amended and Restated Credit Facility Agreement (the “Ninth Amendment”), that amended the Credit Facility, as amended.

19




NOTE 7—WARRANTY RESERVES  

IEC generally warrants its products and workmanship for up to twelve months from date of sale.  As an offset to warranty claims, the Company is sometimes able to obtain reimbursement from suppliers for warranty-related costs or losses.  Based on historical warranty claims experience and in consideration of sales trends, a reserve is maintained for estimated future warranty costs to be incurred on products and services sold through the balance sheet date. The warranty reserve is included in other accrued expenses on the condensed consolidated balance sheets.
 
A summary of additions to and charges against IEC’s warranty reserves during the period follows: 
 
 
Nine Months Ended
Warranty Reserve
 
June 28,
2019
 
June 29,
2018
(in thousands)
 
 

 
 

Reserve, beginning of period
 
$
173

 
$
153

Provision
 
65

 
213

Warranty costs
 
(89
)
 
(199
)
Reserve, end of period
 
$
149

 
$
167

 
NOTE 8—STOCK-BASED COMPENSATION  

The 2019 Stock Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the March 2019 Annual Meeting. The 2019 Plan replaced the 2010 Omnibus Incentive Compensation Plan (“2010 Plan”) that was approved by the Company’s stockholders at the January 2011 Annual Meeting.  The 2019 Plan, like the 2010 Plan, is administered by the Compensation Committee of the Board of Directors and provides for the following types of awards: incentive stock options, nonqualified options, stock appreciation rights, restricted shares, restricted stock units, performance compensation awards, cash incentive awards, director stock and other equity-based and equity-related awards.  Awards are generally granted to certain members of management and employees, as well as directors.  The Company also has an ESPP, adopted in 2011, that provides for the purchase of Company common stock at a discounted stock purchase price. Under the 2019 Plan, 840,360 shares of common stock, plus any shares that are subject to awards granted under the 2010 Plan that expire, are forfeited or canceled without the issuance of shares (other than shares used to pay the exercise price of a stock option under the 2010 Plan and shares used to cover the tax withholding of the award under the 2010 Plan) may be issued over a term of ten years . Under the ESPP, 150,000 shares of common stock may be issued over a term of ten years.

Stock-based compensation expense recorded under the 2010 Plan and the 2019 Plan, totaled $0.1 million and $0.4 million for the three and nine months ended June 28, 2019 , respectively. Stock-based compensation expense recorded under the 2010 Plan and the 2019 Plan, totaled $0.1 million and $0.3 million for the three and nine months ended June 29, 2018 , respectively.

At June 28, 2019 , there were 776,775 remaining shares of common stock available to be issued under the 2019 Plan and 89,701 remaining shares of common stock available to be issued under the ESPP.

Expenses relating to stock options that comply with certain U.S. income tax rules are neither deductible by the Company nor taxable to the employee.  Further information regarding awards granted under the 2010 Plan and ESPP is provided below.

Stock Options
 
When options are granted, IEC estimates fair value using the Black-Scholes option pricing model and recognizes the computed value as compensation cost over the vesting period, which is typically four years.  The contractual term of options granted under the 2010 Plan and 2019 Plan is generally seven years.  The volatility rate is based on the historical volatility of IEC's common stock.
 

20



Assumptions used in the Black-Scholes model and the estimated value of options granted during the nine months ended June 28, 2019 and June 29, 2018 follows in the table below.
 
 
Nine Months Ended
Valuation of Options
 
June 28,
2019
 
June 29,
2018
Assumptions for Black-Scholes:
 
 
 
 
Risk-free interest rate
 
2.35
%
 
2.31
%
Expected term in years
 
5.5

 
5.5

Volatility
 
37
%
 
38
%
Expected annual dividends
 
none

 
none

 
 
 
 
 
Value of options granted:
 
 
 
 
Number of options granted
 
20,000

 
20,000

Weighted average fair value per share
 
$
2.33

 
$
1.53

Fair value of options granted (000s)
 
$
47

 
$
31

 
A summary of stock option activity, together with other related data, follows:
 
 
Nine Months Ended
 
 
June 28, 2019
 
June 29, 2018
Stock Options
 
Number
of Options
 
Wgtd. Avg.
Exercise
Price
 
Number
of Options
 
Wgtd. Avg.
Exercise
Price
Outstanding, beginning of period
 
737,145

 
$
4.33

 
743,045

 
$
4.27

Granted
 
20,000

 
6.12

 
20,000

 
4.00

Exercised
 
(34,000
)
 
4.46

 
(1,400
)
 
4.08

Forfeited
 
(24,250
)
 
3.70

 
(90,000
)
 
4.75

Expired
 
(5,750
)
 
4.06

 
(10,500
)
 
5.24

Outstanding, end of period
 
693,145

 
$
4.40

 
661,145

 
$
4.18

 
 
 
 
 
 
 
 
 
For options expected to vest
 
 
 
 
 
 

 
 

Number expected to vest
 
685,354

 
$
4.39

 
653,922

 
$
4.18

Weighted average remaining contractual term, in years
 
3.4

 
 
 
3.7

 


Intrinsic value (000s)
 
 
 
$
1,306

 
 

 
$
1,009

 
 
 
 
 
 
 
 
 
For exercisable options
 
 
 
 
 
 

 
 

Number exercisable
 
533,645

 
$
4.18

 
450,358

 
$
4.28

Weighted average remaining contractual term, in years
 
2.7

 
 
 
3.4

 
 

Intrinsic value (000s)
 
 
 
$
1,132

 
 

 
$
721

 
 
 
 
 
 
 
 
 
For non-exercisable options
 
 
 
 
 
 

 
 

Expense not yet recognized (000s)
 
 
 
$
232

 
 
 
$
205

Weighted average years to be recognized
 
3.1

 
 
 
1.5

 
 

 
 
 
 
 
 
 
 
 
For options exercised
 
 
 
 
 
 
 
 
Intrinsic value (000s)
 
 
 
$
77

 
 

 
$
2

 

21



Restricted (Non-vested) Stock
 
Certain holders of IEC restricted stock have voting and dividend rights as of the date of grant, and, until vested, the shares may be forfeited and cannot be sold or otherwise transferred.  At the end of the vesting period, which is typically four or five years ( three years in the case of directors), holders have all the rights and privileges of any other common stockholder of the Company.  The fair value of a share of restricted stock is its market value on the date of grant, and that value is recognized as stock compensation expense over the vesting period. 
 
A summary of restricted stock activity, together with related data, follows: 
 
 
Nine Months Ended
 
 
June 28, 2019
 
June 29, 2018
Restricted (Non-vested) Stock
 
Number of Non-vested Shares
 
Wgtd. Avg. Grant Date Fair Value
 
Number of Non-vested Shares
 
Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period
 
103,233

 
$
4.08

 
109,695

 
$
4.01

Granted
 
32,385

 
7.09

 
44,878

 
4.29

Vested
 
(49,511
)
 
4.08

 
(39,300
)
 
4.10

Forfeited
 
(1,400
)
 
4.13

 
(9,490
)
 
4.20

Outstanding, end of period
 
84,707

 
$
5.23

 
105,783

 
$
4.09

 
 
 
 
 
 
 
 
 
For non-vested shares
 
 

 
 
 
 

 
 
Expense not yet recognized (000s)
 
 
 
$
365

 
 

 
$
353

Weighted average remaining years for vesting
 
2.2

 
 
 
1.9

 
 
 
 
 
 
 
 
 
 
 
For shares vested
 
 

 
 
 
 

 
 
Aggregate fair value on vesting dates (000s)
 
 

 
$
333

 
 

 
$
173

 
Stock Issued to Board Members
 
In addition to annual grants of restricted stock, included in the table above, board members may elect to have their meeting fees paid in the form of shares of the Company’s common stock.   The Company has not paid any meeting fees in stock since May 21, 2013. 

Restricted Stock Units

Holders of IEC restricted stock units do not have voting and dividend rights as of the date of grant, and, until vested, the unit may be forfeited and cannot be sold or otherwise transferred.  At the end of the vesting period, which is typically three years, holders will receive shares of the Company's common stock and have all the rights and privileges of any other common stockholder of the Company.  The fair value of a restricted stock unit is the market value of the underlying shares of the Company's stock on the date of grant and that value is recognized as stock compensation expense over the vesting period.


22



A summary of restricted stock unit activity, together with related data, follows:
 
 
Nine Months Ended
 
 
June 28, 2019
 
June 29, 2018
Restricted Stock Units
 
Number of Non-vested Units
 
Wgtd. Avg. Grant Date Fair Value
 
Number of Non-vested Units
 
Wgtd. Avg. Grant Date Fair Value
Outstanding, beginning of period
 
170,492

 
$
3.96

 
267,999

 
$
4.03

Granted
 
63,011

 
7.09

 
102,864

 
4.28

Vested
 
(12,258
)
 
4.64

 

 

Forfeited
 

 

 
(151,341
)
 
4.08

Outstanding, end of period
 
221,245

 
$
4.81

 
219,522

 
$
4.11

 
 
 
 
 
 
 
 
 
For non-vested shares
 
 

 
 
 
 

 
 

Expense not yet recognized (000s)
 
 
 
$
573

 
 

 
$
371

Weighted average remaining years for vesting
 
2.4

 
 
 
2.5

 
 
NOTE 9—INCOME TAXES  

The income tax expense/(benefit) during each of the three and nine months ended June 28, 2019 and June 29, 2018 follows:
 
 
Three Months Ended
 
Nine Months Ended

 
June 28,
2019
 
June 29,
2018
 
June 28,
2019
 
June 29,
2018
(in thousands)
 
 

 

 
 
 
 
Income tax expense/(benefit)
 
$
221

 
$

 
$
736

 
$
(1,005
)
 
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act significantly revised the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates and implementing a territorial tax system. As the Company has a September 30 fiscal year-end, the lower corporate income tax rate was phased in, resulting in a U.S. statutory federal tax rate of approximately 24.2% for fiscal 2018, and 21% for subsequent fiscal years. The Tax Act eliminated the domestic manufacturing deduction and moved to a territorial system. In addition, previously paid federal alternative minimum tax (“AMT”) are now refundable regardless of whether there is future income tax liability before AMT credits.

The Company concluded that the Tax Act caused the Company’s U.S. deferred tax assets and liabilities to be revalued. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are revalued and any change is adjusted through the provision for income tax expense in the reporting period of the enactment.

The income tax provision for interim periods is determined using an estimate of the annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the estimate of the annual effective tax rate is updated, and if the estimated effective tax rate changes, a cumulative adjustment is made. There is a potential for volatility of the effective tax rate due to several factors, including discrete items, changes in the mix and amount of pre-tax income, changes in tax laws, business reorganizations, and settlements with taxing authorities, if any.

For the nine months ended June 29, 2018 , the impact of the Tax Act resulted in the Company recording a net tax benefit of approximately $1.0 million, resulting from the release of the valuation allowance on the Company’s AMT credits.

The Company's estimated annual effective tax rate for fiscal 2019 is comprised of the federal tax rate of 21% plus the state tax rate of 1.58% , which is adjusted for permanent book tax differences. During the three and nine months ended June 28, 2019 , the permanent items included meals and entertainment and stock based compensation. There were no material discrete items recognized in the three and nine months ended June 28, 2019 .


23



NOTE 10—MARKET SECTORS AND MAJOR CUSTOMERS  

A summary of sales, according to the market sector within which IEC’s customers operate, follows:  
 
 
Three Months Ended
 
Nine Months Ended
% of Sales by Sector
 
June 28,
2019
 
June 29,
2018
 
June 28,
2019
 
June 29,
2018
Aerospace & Defense
 
61%
 
60%
 
59%
 
62%
Medical
 
22%
 
22%
 
22%
 
21%
Industrial
 
17%
 
18%
 
19%
 
17%
 
 
100%
 
100%
 
100%
 
100%

One individual customer represented 10% or more of sales for the three months ended June 28, 2019 . This customer was from the aerospace & defense sector and represented 24% of sales. One individual customer represented 10% or more of sales for the nine months ended June 28, 2019 . This customer was from the aerospace & defense sector and represented 22% of sales.

Two individual customers each represented 10% or more of sales for the three months ended June 29, 2018 . One customer was from the aerospace & defense sector and represented 25% of sales, while one was from the medical sector and represented 11% of sales for the three months ended June 29, 2018 . Two individual customers each represented 10% or more of sales for the nine months ended June 29, 2018 . One customer was from the aerospace & defense sector and represented 23% of sales, while one customer was from the medical sector and represented 11% of sales for the six months ended June 29, 2018 .

One individual customer represented 10% or more of receivables and accounted for 26% of the outstanding balance at June 28, 2019 . Three individual customers represented 10% or more of receivables and accounted for 55% of the outstanding balance at September 30, 2018 .

Credit risk associated with individual customers is periodically evaluated by analyzing the entity’s financial condition and payment history.  Customers generally are not required to post collateral.

NOTE 11—COMMITMENTS AND CONTINGENCIES

Litigation

From time to time, the Company may be involved in legal actions in the ordinary course of its business, but management does not believe that any such proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s condensed consolidated financial statements.

NOTE 12—CAPITAL LEASE

Leases

A summary of capital lease payments for the next five years follows:
Capital Lease Payment Schedule
 
Contractual
Principal
Payments
(in thousands)
 
 

Twelve months ending June
 
 

2020
 
$
669

2021
 
683

2022
 
696

2023
 
711

2024 and thereafter
 
6,900

Total capital lease payments
 
9,659

Less: amounts representing interest
 
(2,556
)
Present value of minimum lease payment
 
$
7,103



24



NOTE 13—NET INCOME PER SHARE

The Company applies the two-class method to calculate and present net income per share. Certain of the Company's restricted (non-vested) share awards contain non-forfeitable rights to dividends and are considered participating securities for purposes of computing net income per share pursuant to the two-class method. Under the two -class method, net earnings are reduced by the amount of dividends declared (whether paid or unpaid) and the remaining undistributed earnings are then allocated to common stock and participating securities, based on their respective rights to receive dividends.

Basic earnings per common share are calculated by dividing income available to common stockholders by the weighted average number of shares outstanding during each period.  Diluted earnings per common share add to the denominator incremental shares resulting from the assumed exercise of all potentially dilutive stock options, as well as unvested restricted stock and restricted stock units.  Options, restricted stock and restricted stock units are primarily held by directors, officers and certain employees. 

The Company uses the two-class method to calculate net income per share as both classes share the same rights in dividends. Therefore, basic and diluted earnings per share (“EPS”) are the same for both classes of ordinary shares.

A summary of shares used in the EPS calculations follows (in thousands except share and per share data):
 
 
Three Months Ended
 
Nine Months Ended
Earnings Per Share
 
June 28,
2019
 
June 29,
2018
 
June 28,
2019
 
June 29,
2018
Basic net income per share:
 
 
 
 
 
 
 
 
Net income
 
$
1,211

 
$
204

 
$
2,953

 
$
1,289

Less: Income attributable to non-vested shares
 
10

 
2

 
25

 
13

Net income available to common stockholders
 
$
1,201

 
$
202

 
$
2,928

 
$
1,276

 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding
 
10,332,548

 
10,243,286

 
10,294,173

 
10,221,869

 
 
 
 
 
 
 
 
 
Basic net income per share
 
$
0.12

 
$
0.02

 
$
0.28

 
$
0.12

 
 
 
 
 
 
 
 
 
Diluted net income per share:
 
 
 
 
 
 
 
 
Net income
 
$
1,211

 
$
204

 
$
2,953

 
$
1,289

Shares used in computing basic net income per share
 
10,332,548

 
10,243,286

 
10,294,173

 
10,221,869

Dilutive effect of non-vested shares
 
309,855

 
313,478

 
262,780

 
245,243

Shares used in computing diluted net income per share
 
10,642,403

 
10,556,764

 
10,556,953

 
10,467,112

 
 
 
 
 
 
 
 
 
Diluted net income per share
 
$
0.11

 
$
0.02

 
$
0.28

 
$
0.12


The diluted weighted average share calculations do not include the following shares, which are not dilutive to the EPS calculations.
 
 
Three Months Ended
 
Nine Months Ended
 
 
June 28,
2019
 
June 29,
2018
 
June 28,
2019
 
June 29,
2018
Anti-dilutive shares excluded
 
52,523

 
39,335

 
39,872

 
171,791



25




NOTE 14—SUBSEQUENT EVENTS

Effective as of July 8, 2019, the Company and M&T Bank entered into the Ninth Amendment to the Credit Facility, as amended. The Ninth Amendment increased the Company’s revolving credit commitment to $35.0 million . In addition, the Ninth Amendment modified the definition of “Borrowing Base” to increase the amount of certain availability limits contained within the definition.

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
The information in this Management’s Discussion and Analysis should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and notes.  All references to “Notes” are to the accompanying condensed consolidated financial statements and notes included in this Quarterly Report on Form 10-Q (“Form 10-Q”).
 
Cautionary Note Regarding Forward-Looking Statements

References in this report to “IEC,” the “Company,” “we,” “our,” or “us” mean IEC Electronics Corp. and its subsidiaries except where the context otherwise requires. This Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. These forward-looking statements include, but are not limited to, statements regarding future sales and operating results, future prospects, the capabilities and capacities of business operations, any financial or other guidance and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events. The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events and is subject to various uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.

The following important factors, among others, could affect future results and events, causing those results and events to differ materially from those views expressed or implied in our forward-looking statements: business conditions and growth or contraction in our customers’ industries, the electronic manufacturing services industry and the general economy; variability of our operating results; our ability to control our material, labor and other costs; our dependence on a limited number of major customers; the potential consolidation of our customer base; availability of component supplies; dependence on certain industries; variability and timing of customer requirements; technological, engineering and other start-up issues related to new programs and products; uncertainties as to availability and timing of governmental funding for our customers; the impact of government regulations, including FDA regulations; risks related to the accuracy of the estimates and assumptions we used to revalue our net deferred tax assets in accordance with the Tax Cuts and Jobs Act of 2017; the types and mix of sales to our customers; litigation and governmental investigations; intellectual property litigation; our ability to maintain effective internal controls over financial reporting; unforeseen product failures and the potential product liability claims that may be associated with such failures; the availability of capital and other economic, business and competitive factors affecting our customers, our industry and business generally; failure or breach of our information technology systems; and natural disasters. Any one or more of such risks and uncertainties could have a material adverse effect on us or the value of our common stock. For a further list and description of various risks, relevant factors and uncertainties that could cause future results or events to differ materially from those expressed or implied in our forward-looking statements, see the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this Form 10-Q, our Annual Report on Form 10-K for the fiscal year ended September 30, 2018 , and our other filings with the Securities and Exchange Commission (the “SEC”).

All forward-looking statements included in this Form-10-Q are made only as of the date indicated or as of the date of this Form 10-Q. We do not undertake any obligation to, and may not, publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or which we hereafter become aware of, except as required by law. New risks and uncertainties arise from time to time and we cannot predict these events or how they may affect us and cause actual results to differ materially from those expressed or implied by our forward-looking statements. Therefore, you should not rely on our forward-looking statements as predictions of future events. When considering these risks, uncertainties and assumptions, you should keep in mind the cautionary statements contained in this report and any documents incorporated herein by reference. You should read this document and the documents that we reference in this Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.


26



Overview

IEC Electronics Corp. (“IEC,” “we,” “our,” “us,” the “Company”) conducts business directly, as well as through its subsidiaries, IEC Electronics Corp-Albuquerque (“Albuquerque”); IEC Analysis & Testing Laboratory, LLC (“ATL”); and IEC California Holdings, Inc. The Rochester unit operates as a division of IEC.

We are a premier provider of electronic manufacturing services (“EMS”) to advanced technology companies that produce life-saving and mission critical products for the medical, industrial, aerospace and defense sectors. We specialize in delivering technical solutions for the custom manufacturing, product configuration, and verification testing of highly engineered complex products that require a sophisticated level of manufacturing to ensure quality and performance.

Within the EMS sector, we have unique capabilities which allow our customers to rely on us to solve their complex challenges, minimize their supply chain risk and deliver full system solutions for their supply chain. These capabilities include, among others:

Our engineering services include the design, development, and fabrication of customized stress testing platforms to simulate a product’s end application, such as thermal cycling and vibration, in order to ensure reliable performance and avoid catastrophic failure when the product is placed in service.
Our vertical manufacturing model offers customers the ability to simplify their supply chain by utilizing a single supplier for their critical components including complex printed circuit board assembly (“PCBA”), precision metalworking, and interconnect solutions. This service model allows us to control the cost, lead time, and quality of these critical components which are then integrated into full system assemblies and minimizes our customers’ supply chain risk.
We provide direct order fulfillment services for our customers by integrating with their configuration management process to obtain their customer orders, customize the product to the specific requirements, functionally test the product and provide verification data, and direct ship to their end customer in order to reduce time, cost, and complexity within our customer's supply chain.
We are the only EMS provider with an on-site laboratory that has been approved by the Defense Logistics Agency (“DLA”) for their Qualified Testing Supplier List (“QTSL”) program which deems the site suitable to conduct various QTSL and military testing standards including counterfeit component analysis. In addition, this advanced laboratory is utilized for complex design analysis and manufacturing process development to solve challenges and accelerate our customers’ time to market.

We are a 100% U.S. manufacturer which attracts customers who are unlikely to utilize offshore suppliers due to the proprietary nature of their products, governmental restrictions or volume considerations. Our locations include:

Newark, New York - Located approximately one hour east of Rochester, New York, our Newark location is our corporate headquarters and is the largest manufacturing location providing complex circuit board manufacturing, interconnect solutions, and system-level assemblies along with an on-site material analysis laboratory for advanced manufacturing process development.
Rochester, New York - Focuses on precision metalworking services including complex metal chassis and assemblies.
Albuquerque, New Mexico - Specializes in the aerospace and defense markets with complex circuit board and system-level assemblies along with a state of the art analysis and testing laboratory which conducts counterfeit component analysis and complex design analysis.

We excel at complex, highly engineered products that require sophisticated manufacturing support where quality and reliability are of paramount importance. With our customers at the center of everything we do, we have created a high-intensity, rapid response culture capable of reacting and adapting to their ever-changing needs.  Our customer-centric approach offers a high degree of flexibility while simultaneously complying with rigorous quality and on-time delivery standards.

We proactively invest in areas we view as important for our continued long-term growth. All of our locations are ISO 9001:2008 certified and ITAR registered. We are Nadcap accredited and AS9100D and AS9100C certified at our Newark and Albuquerque locations, respectively, to support the stringent quality requirements of the aerospace industry. Our Newark location is ISO 13485 certified to serve the medical sector and is an approved supplier by the National Security Agency (“NSA”) under the COMSEC standard regarding communications security. Our analysis & testing laboratory in Albuquerque is ISO 17025 accredited, an IPC-approved Validation Services Test Laboratory, and is the only on-site EMS laboratory that has been approved by the DLA for their QTSL program which deems the site suitable to conduct various QTSL and military testing standards including counterfeit component analysis. Albuquerque also performs work per NASA-STD-8739 and J-STD-001ES space standards.


27



The technical expertise of our experienced workforce enables us to build some of the most advanced electronic, wire and cable, interconnect solutions, and precision metal systems sought by original equipment manufacturers (“OEMs”).

Employees are our single greatest resource. Our total employees numbered 850, all of which are full time employees, at June 28, 2019 . Total employment increased by 52 employees during the three months ended June 28, 2019 , our third quarter of fiscal 2019 . Some of our full-time employees are temporary employees. We make a concerted effort to engage our employees in initiatives that improve our business and provide opportunities for growth, and we believe that our employee relations are good. We have access to large and technically qualified workforces in close proximity to our operating locations in Rochester, NY and Albuquerque, NM.

Three Months Results
 
A summary of selected income statement amounts for the three months ended follows:
 

Three Months Ended
Income Statement Data

June 28,
2019
 
June 29,
2018
(in thousands)

 
 

Net sales

$
40,324

 
$
29,782



 
 
 
Gross profit

5,605

 
3,359

Selling and administrative expenses

3,721

 
2,833

Interest and financing expense

452

 
322

Income before income taxes

1,432

 
204

Income tax expense
 
221

 

Net income
 
$
1,211

 
$
204

 
A summary of sales, according to the market sector within which our customers operate, follows:
 
 
Three Months Ended
% of Sales by Sector
 
June 28,
2019
 
June 29,
2018
 
 
 
 
 
Aerospace & Defense
 
61%
 
60%
Medical
 
22%
 
22%
Industrial
 
17%
 
18%
 
 
100%
 
100%
 
Revenue increased in the third quarter of fiscal 2019 by $10.5 million or 35% as compared to the third quarter of the prior fiscal year. Revenues from the aerospace & defense sector increase d $7.6 million , revenue from the medical sector increase d $1.9 million and revenue from the industrial sector increase d $1.0 million .
 
Various increases and decreases in sales to our aerospace & defense customers resulted in a net increase of $7.6 million in the third quarter of fiscal 2019 . Ramping up of production of various customers resulted in an increase of revenue of $5.1 million and increases in customer demand resulted in an additional $3.2 million increase in revenue. These increases were partially offset by decreases related to contracts ending of $0.5 million .

The medical sector saw an increase of $1.9 million in the third quarter of fiscal 2019 compared to the same period of the prior fiscal year. We saw increases related to new programs ramping up with three customers amounting to $1.8 million . One customer had material constraints removed during the period, which resulted in increased revenue of $0.5 million . These increases were partially offset by net reductions of $0.5 million in demand from multiple customers. We continue to expect some volatility in the medical sector going forward.

The net increase in the industrial sector of $1.0 million resulted primarily from the production ramp up of new programs with two customers, which amounted to $1.0 million . The remaining change was minimal and was due to several customers whose end markets have grown, partially offset by decreases in demand from other customers.


28



Gross profit as a percent of sales for the third quarter of fiscal 2019 increased to 13.9% of sales versus 11.3% of sales in the third quarter of the prior fiscal year. Customer mix had the most significant impact on gross profit. In addition, the growth in sales allowed for more absorption of overhead costs.

Selling and administrative (“S&A”) expense increased $0.9 million and represented 9.2% of sales in the third quarter of fiscal 2019 compared to 9.5% of sales in the same quarter of the prior fiscal year. The increase in S&A expense was primarily due to higher wage and related expenses.

Interest expense increased by $0.1 million in the third quarter of fiscal 2019 compared to the same quarter of the prior fiscal year. The weighted average interest rate on our debt was consistent during the third quarter of fiscal 2019 compared to the third quarter of the prior fiscal year. Our average outstanding debt balances increased by $7.8 million in the third quarter of fiscal 2019 compared to the third quarter of fiscal 2018 because of higher balances on the revolving credit facility and equipment line advances and term loans to fund capital purchases. Cash paid for interest on credit facility debt was approximately $0.3 million for each of the third quarter of fiscal 2019 and fiscal 2018. Detailed information regarding our borrowings is provided in Note 6—Credit Facilities .

With respect to tax payments, in the near term, we expect to be largely sheltered by sizable net operating loss (“NOL”) carryforwards for federal income tax purposes. In the quarter ended June 28, 2019 , we did not pay any taxes. At the end of fiscal 2018 , the gross NOL carryforwards amounted to approximately $29.7 million. The NOL carryforwards expire in varying amounts between 2022 and 2035, unless utilized prior to these dates.

Year to Date Results

A summary of selected income statement amounts for the nine months ended follows:
 
 
Nine Months Ended
 
 
June 28,
2019
 
June 29,
2018
(in thousands)
 
 
 
 
Net sales
 
$
113,059

 
$
82,706

 
 
 
 
 
Gross profit
 
15,251

 
9,661

Selling and administrative expenses
 
10,402

 
8,543

Interest and financing expense
 
1,160

 
834

Income before income taxes
 
3,689

 
284

Income tax expense/(benefit)
 
736

 
(1,005
)
Net income
 
$
2,953

 
$
1,289


A summary of sales, according to the market sector within which our customers operate, follows:
 
 
Nine Months Ended
% of Sales by Sector
 
June 28,
2019
 
June 29,
2018
 
 
 
 
 
Aerospace & Defense
 
59%
 
62%
Medical
 
22%
 
21%
Industrial
 
19%
 
17%
 
 
100%
 
100%

Revenue increased in the first nine months of fiscal 2019 by $30.4 million or 37% as compared to the first nine months of the prior fiscal year. Revenues from the aerospace & defense sector increase d $16.3 million , revenue from the medical sector increased $7.8 million and revenue from the industrial sector increase d $6.3 million .
 
Various increases and decreases in sales to our aerospace & defense customers resulted in a net increase of $16.3 million in the first nine months of fiscal 2019 . We saw an increase of $11.1 million related to production ramp up from multiple customers. Various increases and decreases in demand from existing customers resulted in a net increase of $8.8 million . The remaining net decrease of $3.6 million was due to disengagement with two customers and additional programs ending.

29




Revenues in the medical sector increased by $7.8 million in the first nine months of fiscal 2019 compared to the same period of the prior fiscal year. We saw an increase of $7.2 million related to production ramp up for three customers and an increase in demand from another customer of $3.0 million . These increases were partially offset by volume reductions from multiple customers of $2.4 million . We expect some volatility in the medical sector going forward.

The net increase in the industrial sector of $6.3 million resulted primarily from the production ramp up of new programs with three customers, which amounted to $5.7 million . The remaining increase was due to several customers whose end markets have grown, partially offset by decreases in demand from other customers.

Gross profit for the first nine months of fiscal 2019 increased to 13.5% of sales versus 11.7% in the first nine months of the prior fiscal year. Customer mix had the most significant impact on gross profit. In addition, the growth in sales allowed for more absorption of overhead costs.

Selling and administrative (“S&A”) expense increased $1.9 million and represented 9.2% of sales in the first nine months of fiscal 2019 compared to 10.3% of sales in the first nine months of the prior fiscal year. The increase in S&A expense was primarily due to higher wage and related expenses.

Interest expense increased by $0.3 million in the first nine months of fiscal 2019 compared to the first nine months of the prior fiscal year. The weighted average interest rate on our debt was 0.64% higher during the first nine months of fiscal 2019 compared to the first nine months of the prior fiscal year. Our average outstanding debt balances increased by $6.1 million in the first nine months of fiscal 2019 compared to the first nine months of fiscal 2018 because of higher balances on the revolving credit facility and equipment line advances and term loans to fund capital purchases. Cash paid for interest on credit facility debt was approximately $0.9 million and $0.6 million for the first nine months of fiscal 2019 and fiscal 2018, respectively. Detailed information regarding our borrowings is provided in Note 6—Credit Facilities .

With respect to tax payments, in the near term, we expect to be largely sheltered by sizable NOL carryforwards for federal income tax purposes. In the nine months ended June 28, 2019 , we paid minimal taxes. At the end of fiscal 2018 , the gross NOL carryforwards amounted to approximately $29.7 million. The NOL carryforwards expire in varying amounts between 2022 and 2035, unless utilized prior to these dates.

Liquidity and Capital Resources
 
Capital Resources
 
As of June 28, 2019 , there were $0.9 million of outstanding capital expenditure commitments for manufacturing equipment.  We generally fund capital expenditures with cash flows from operations, our revolving credit facility and our equipment line advances. Based on our current expectations, we believe that our projected cash flows provided by operations and potential borrowings under the revolving credit facility and equipment line advances, are sufficient to meet our working capital, debt service and capital expenditure requirements for the next twelve months.

Our cash management system provides for the funding of the disbursement accounts on a daily basis as checks are presented for payment. Under this system, outstanding checks in excess of the bank balance create a book overdraft.
 

30



Summary of Cash Flows
 
A summary of selected cash flow amounts for the nine months ended June 28, 2019 and June 29, 2018 follows:
 
 
Nine Months Ended
Cash Flow Data
 
June 28,
2019
 
June 29,
2018
(in thousands)
 
 
 
 
Cash, beginning of period
 
$

 
$

Net cash provided by/(used in):
 
 

 
 

Operating activities
 
(9,242
)
 
(3,748
)
Investing activities
 
(1,099
)
 
(49
)
Financing activities
 
10,341

 
3,797

Net cash change for the period
 

 

Cash, end of period
 
$

 
$

 
Operating activities
 
Cash flows from operations, before considering changes in our working capital accounts, provided $6.1 million and $2.4 million for the first nine months of fiscal 2019 and fiscal 2018 , respectively. Net income of $3.0 million in the first nine months of fiscal 2019 improved compared to the same period of the prior fiscal year mainly due to increased sales. Net income was $1.3 million during the first nine months of the prior fiscal year, largely due to the income tax benefit of $1.0 million as a result of the Tax Act.

Working capital used cash flows of $15.3 million in the first nine months of fiscal 2019 and used $6.1 million in the first nine months of fiscal 2018 . The change in working capital in the first nine months of fiscal 2019 was primarily due to increase s in inventory of $14.5 million , increase s in accounts receivable of $1.4 million , increase s in unbilled contract revenue of $3.0 million due to the implementation of ASC 606, and a decrease in book overdraft of $0.6 million . These changes were partially offset by increase s in accounts payable of $1.3 million , increase s in accrued expenses of $1.4 million and increase s in customer deposits of $2.2 million . Inventory and customer deposit increases were driven by the higher customer demand to meet increased backlog and securing materials for future production. The increase in accounts receivable was primarily due to increases in sales. The increase in accounts payable was due primarily to an increase of inventory purchases, as well as timing of purchases and payments. The increase in accrued expenses was due to an increase in payroll and related costs due to timing.

Investing activities
 
Cash flows used in investing activities were $1.1 million for the first nine months of fiscal 2019 .  Cash flows used in investing activities were minimal for the first nine months of fiscal 2018 .  Cash flows used in each of the first nine months of fiscal 2019 and fiscal 2018 consisted of purchases of equipment. Cash flows used in the first nine months of fiscal 2018 also consisted of capitalized software costs resulting from the ongoing implementation of a new enterprise resource planning (“ERP”) system, these purchases were offset by the proceeds from the Rochester sale-leaseback transaction.

Financing activities
 
Cash flows provided by financing activities were $10.3 million for the first nine months of fiscal 2019 and $3.8 million for the first nine months of fiscal 2018 .  During the first nine months of fiscal 2019 , net borrowings under all credit facilities were $10.5 million , with $11.0 million of net borrowings under the Revolver, as defined below, repayments of $0.9 million for term debt, and $0.4 million of new borrowings related to equipment line advances. During the first nine months of fiscal 2018 , net borrowings under all credit facilities were $4.0 million , with $5.8 million of net borrowings under the Revolver, as defined below, repayments of $2.7 million for term debt, and $0.8 million of new borrowings related to equipment line advances. Term debt repayments in the first nine months of fiscal 2018, included more than normal principal repayments as proceeds from the Rochester sale-leaseback transaction were used to pay down term debt.


31



Credit Facilities
 
At June 28, 2019 , borrowings outstanding under the revolving credit facility (the “Revolver”) under the Eighth Amendment to the Fifth Amended and Restated Credit Facility Agreement (which amended the Fifth Amended and Restated Credit Facility Agreement dated as of December 14, 2015, as amended by various amendments (collectively, the “Credit Facility, as amended”) amounted to $24.0 million , and the upper limit was $27.0 million .  We believe that our liquidity is sufficient to satisfy anticipated operating requirements during the next twelve months.

The Credit Facility, as amended, contains various affirmative and negative covenants including financial covenants. As of June 28, 2019 , the Company had to maintain a minimum fixed charge coverage ratio (“Fixed Charge Coverage Ratio”). The Fixed Charge Coverage Ratio compares (i) EBITDAS minus unfinanced capital expenditures minus tax expense, to (ii) the sum of interest expense, principal payments, payments on all capital lease obligations and dividends, if any (fixed charges). “EBITDAS” is defined as earnings before interest, taxes, depreciation, amortization and non-cash stock compensation expense. The Fixed Charge Coverage Ratio was measured for a trailing twelve months ended June 28, 2019 . The Credit Facility, as amended, also provides for customary events of default, subject in certain cases to customary cure periods, in which events, the outstanding balance and any unpaid interest would become due and payable.

Pursuant to the Credit Facility, as amended, the Fixed Charge Coverage Ratio covenant of a minimum of 1.10 was the only covenant in effect at June 28, 2019 . The Fixed Charge Coverage Ratio was calculated as 2.22 at June 28, 2019 . The Company was in compliance with the financial debt covenant at June 28, 2019 .

Detailed information regarding our borrowings at June 28, 2019 is provided in Note 6—Credit Facilities .

Off-Balance Sheet Arrangements
 
IEC is not a party to any material off-balance sheet arrangements.
 
Application of Critical Accounting Policies
 
Our application of critical accounting policies is disclosed in our Annual Report on Form 10-K filed for the fiscal year ended September 30, 2018 .  During the nine months ended June 28, 2019 , the following critical accounting policies were updated as a result of the adoption of FASB Accounting Standard Update 2014-09, “Revenue from Contracts with Customers” (“ASC 606”) and are affected significantly by judgments, assumptions and estimates used in the preparation of the consolidated financial statements. We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.

Revenue recognition: Revenue is derived primarily from the sale of electronics components that are built to customer specifications. For revenue recognized over time, the Company uses an input measure to determine progress towards completion. Under this method, sales and gross profit are recognized as work is performed generally based on the relationship between the actual costs incurred and the total estimated costs at completion. If the Company has an enforceable right to payment for work completed to date, with a recapture of costs incurred plus an applicable margin, and the goods do not have an alternative future use once the manufacturing process has commenced, then the Company records an unbilled revenue associated with non-cancellable customer orders. Similarly, the Company records an unbilled revenue related to its WIP inventory when the manufacturing process has commenced and there is a non-cancellable customer purchase order.

Estimation of the percentage of completion in satisfying its performance obligation: The Company records an unbilled contract revenue for revenue related to its WIP when the manufacturing process has commenced and there is a non-cancellable customer purchase order. The Company uses direct manufacturing labor inputs to estimate the percentage of completion in satisfying its performance obligation associated with WIP inventory. If assumptions change related to the estimate of the performance obligation associated with WIP inventory, this could have a material impact on the revenue and corresponding margin recognized.

Recently Issued Accounting Standards
 
See Note 1—Our Business and Summary of Significant Accounting Policies for further information concerning recently issued accounting pronouncements.
 
Item 3.    Quantitative and Qualitative Disclosures About Market Risk
 
As a result of its financing activities, the Company is exposed to changes in interest rates that may adversely affect operating results. The Company actively monitors its exposure to interest rate risk and from time to time may use derivative financial

32



instruments to manage the impact of this risk.  The Company may use derivatives only for the purpose of managing risk associated with underlying exposures.  The Company does not trade or use instruments with the objective of earning financial gains on the interest rate nor does the Company use derivatives instruments where it does not have underlying exposure.  The Company did not have any derivative financial instruments at June 28, 2019 or September 30, 2018 .
 
At June 28, 2019 , the Company had $28.3 million of debt, all comprised of variable interest rates.  Interest rates on variable loans are based on London interbank offered rate (“LIBOR”). The credit facilities are more fully described in Note 6—Credit Facilities .  Interest rates based on LIBOR currently adjust daily, causing interest on such loans to vary from period to period.  A sensitivity analysis as of June 28, 2019 indicated that a one-percentage point increase or decrease in our variable interest rates, which represents more than a 10% change, would increase or decrease the Company’s annual interest expense by approximately $0.3 million.
 
The Company is exposed to credit risk to the extent of non-performance by M&T Bank under the Credit Agreement, as amended.  M&T Bank’s credit rating (reaffirmed A by Fitch in September 2018) is monitored by the Company, and IEC expects that M&T Bank will perform in accordance with the terms of the Credit Agreement, as amended.
 
Item 4.    Controls and Procedures
 
Evaluation of disclosure controls and procedures

Our management, with the participation of our Chief Executive Officer (our principal executive officer) and our Chief Financial
Officer (our principal financial officer), evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of June 28, 2019 , the end of the period covered by this Form 10-Q.  Based on that evaluation, our Chief Executive Officer concluded that, as of June 28, 2019 , our disclosure controls and procedures were effective.

Changes in internal control over financial reporting

The Company is in the process of implementing a financial reporting system, Epicor ERP Software (“Epicor”), as part of a multi-year plan to integrate and upgrade our systems and processes.  During the nine months ended June 28, 2019 , the Company began implementation of Epicor by converting one legacy ERP system to Epicor. The implementation of other legacy ERP systems to Epicor is occurring in phases and is expected to be completed after fiscal 2019.  

As part of the Epicor implementation, certain changes to our processes and procedures have and will continue to occur.  These changes will result in changes to our internal control over financial reporting.  While Epicor is designed to strengthen our internal financial controls by automating certain manual processes and standardizing business processes and reporting across our organization, management will continue to evaluate and monitor our internal controls as each of the affected areas evolve.

During the quarter ended  June 28, 2019 , there have been no other changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the effectiveness of control systems

IEC’s management does not expect that our disclosure controls and internal controls will prevent all errors and fraud. Because of inherent limitations in any such control system (e.g. faulty judgments, human error, information technology system error, or intentional circumvention), there can be no assurance that the objectives of a control system will be met under all circumstances. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The benefits of a control system also must be considered relative to the costs of the system and management’s judgments regarding the likelihood of potential events. In summary, there can be no assurance that any control system will succeed in achieving its goals under all possible future conditions, and as a result of these inherent limitations, misstatements due to error or fraud may occur and may or may not be detected.

33



Part II         OTHER INFORMATION
 
Item 1.    Legal Proceedings
 
From time to time, we may be involved in legal actions in the ordinary course of our business, but management does not believe that any such proceedings individually or in the aggregate, will have a material effect on our condensed consolidated financial statements.

Item 1A.   Risk Factors
 
There have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended September 30, 2018 filed with the SEC on November 29, 2018 .

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3.    Defaults Upon Senior Securities
 
None
 
Item 4.    Mine Safety Disclosures
 
Not Applicable
 
Item 5.     Other Information  

None
 
Item 6.    Exhibits
 
INDEX TO EXHIBITS
Exhibit No.
 
Description
10.1
 
10.2*#
 
10.3*#
 
10.4*#
 
10.5*#
 
10.6*#
 
31.1*
 
31.2*
 
32.1*
 
101
 
The following items from this Quarterly Report on Form 10-Q formatted in Extensible Business Reporting Language: (i) Consolidated Balance Sheets (unaudited), (ii) Consolidated Income Statements (unaudited), (iii) Consolidated Statements of Changes in Stockholders’ Equity (unaudited), (iv) Consolidated Statements of Cash Flows (unaudited), and (v) Notes to Consolidated Financial Statements. 

# Filed herewith.

* Management contract or compensatory plan.



34




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
IEC Electronics Corp.
 
 
(Registrant)
 
 
 
August 7, 2019
By:
/s/ Thomas L. Barbato
 
 
Thomas L. Barbato
 
 
Senior Vice President and Chief Financial Officer
 
 
(On behalf of the Registrant and as Principal Financial and Accounting Officer)
 

35
Exhibit 10.2



IEC ELECTRONICS CORP.

2019 STOCK INCENTIVE PLAN
RESTRICTED STOCK AWARD AGREEMENT
This Restricted Stock Award Agreement (this “ Award Agreement ”) is made and entered into as of [_______________], 20__ (the “ Date of Grant ”), by and between IEC Electronics Corp. (the “ Company ”) and ___________________ (the “ Participant ”). Capitalized terms not defined in this Award Agreement shall have the respective meanings given such terms by the IEC Electronics Corp. 2019 Stock Incentive Plan (the “ Plan ”).
1. Award . The Company hereby grants to the Participant an Award (the “ Award ”) of Restricted Stock of [________] shares of Stock (the “ Restricted Stock ”), subject to the provisions of the Plan and to the terms and conditions of this Award Agreement.

2. Restrictions on Transfer . Except as otherwise provided in this Award Agreement, until the shares of Restricted Stock vest, the shares of Restricted Stock may not be sold, exchanged, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent and distribution, and they shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation, or other disposition of the shares of Restricted Stock contrary to the provisions hereof, and the levy of any execution, attachment, or similar process upon the shares of Restricted Stock, shall be null and void and without effect.

3. Vesting . Except as otherwise provided by the Participant’s employment agreement (if any), subject to the provisions of the Plan and this Award Agreement, and subject to the Participant’s continued employment with the Company or any of its Affiliates through such date, [________] of the shares of Restricted Stock will vest on [________] (each such date a “ Vesting Date ”).

4. Acceleration of Vesting . Notwithstanding the provisions of Section 3 above, the restrictions set forth in this Award Agreement will immediately lapse and the shares of Restricted Stock will immediately vest upon the occurrence of any of the following events prior to the Vesting Date: (a) the Participant’s death; (b) the Participant’s Disability; (c) the Participant’s Retirement (as defined below); (d) a Change in Control if either (i) the employment of the Participant is terminated or (ii) the acquirer does not agree to assume or substitute the shares of Restricted Stock for similar awards on shares of acquirer’s common stock; or (e) the occurrence of any other event or condition for which the Participant’s employment agreement (if any) provides for accelerated vesting. “ Retirement ” means termination of employment with the Company or any of its Affiliates if such termination of employment constitutes normal retirement, early retirement, disability retirement or other retirement as provided for at the time of such termination of employment under the applicable retirement program then maintained by the Company or any of its Affiliates provided that the Participant does not continue in the employment of the Company or any of its Affiliates.

5. Termination of Employment; Detrimental Activities .

(a) Except as otherwise provided by the Participant’s employment agreement (if any), all rights in and to any and all shares of Restricted Stock granted pursuant to this Award Agreement, which have not vested as described in Section 3 or 4 above, shall be forfeited upon: (i) the Participant’s termination of employment with the Company and its Affiliates for any reason, whether with or without Cause, other than



Exhibit 10.2


the Participant’s death, Disability or Retirement or a Change in Control; or (ii) a determination by the Committee that the Participant engaged in Detrimental Activity. “ Detrimental Activity ” shall include: (A) the rendering of services for any organization or engaging directly or indirectly in any business which is or becomes competitive with the Company or any Affiliate, or which organization or business, or the rendering of services to such organization or business, is or becomes otherwise prejudicial to or in conflict with the interests of the Company or any Affiliate; (B) the disclosure to anyone outside the Company or any of its Affiliates, or the use in other than the Company’s business, without prior written authorization from the Company, of any confidential information or material relating to the business of the Company or any of its Affiliates, acquired by the Participant either during or after employment with the Company or an Affiliate; (C) activity that results in termination of the Participant’s employment for Cause; (D) a violation of any rules, policies, procedures or guidelines of the Company or an Affiliate, including, but not limited to, the Company’s Code of Business Conduct and Ethics; (E) any attempt, directly or indirectly, to induce any employee of the Company or any Affiliate to be employed or perform services elsewhere or any attempt, directly or indirectly, to solicit the trade or business of any current or prospective customer, supplier or partner of the Company or any Affiliate; or (F) any other conduct or act determined by the Board to be injurious, detrimental or prejudicial to any interest of the Company or any Affiliate.

(b) Notwithstanding the foregoing, nothing in Section 5(a) above: (i) prohibits the Participant from making reports of possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice and the Securities and Exchange Commission, in accordance with the provisions and rules of Section 21F of the Exchange Act, Section 806 of the Sarbanes-Oxley Act of 2002, or of any other whistleblower protection provisions of state or federal law or regulation, or (ii) requires notification or prior approval by the Company of any such report; provided that, the Participant is not authorized to disclose communications with counsel that were made for the purpose of receiving legal advice or that contain legal advice or that are protected by the attorney work product or similar privilege. Furthermore, the Participant shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.

6. Recoupment .

(a) Recoupment . As provided by Section 6.9 of the Plan, notwithstanding anything in the Plan or this Award Agreement, the Company will be entitled to the extent required by applicable law (including, without limitation, Section 10D of the Exchange Act and any regulations promulgated with respect thereto) or Exchange listing conditions, in each case as in effect from time to time, to recoup compensation of whatever kind paid under this Award Agreement by the Company at any time.
 
(b) Repayment of Gain; Setoff . If the Participant engages in Detrimental Activity prior to or during the six months after shares of Stock vest pursuant to Section 3 or 4 above, such shares may be forfeited within two years thereafter. In the event of any such forfeiture, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of the forfeiture in such manner and on such terms and conditions as may be required, and the Company shall be entitled to setoff against the amount of any such gain any amount owed to the Participant by the Company or any Affiliate.
 
7. Withholding of Taxes . The Company and its Affiliates shall have the right, in its discretion, to deduct from the Participant’s remuneration or withhold shares of Stock that would otherwise be issuable or deliverable to the Participant as a result of vesting in satisfaction of the federal, state, local or foreign



Exhibit 10.2


income or other taxes required by law to be withheld with respect to such issuance or vesting (or such higher amount that would not have an adverse tax effect). Shares of Stock tendered as payment of required tax withholding shall be valued at the fair market value of the Company’s Stock on the date such tax withholding obligation arises. It shall be a condition to the obligation of the Company to release the shares of Stock from the vesting of the Restricted Stock that the Participant pay to the Company or an Affiliate, upon its demand, such amount as may be requested by the Company or the Affiliate for the purpose of satisfying any liability to withhold federal, state, local or foreign income or other taxes. If the amount requested is not paid, the Company may refuse to release the shares of Stock.

8. Stock Certificates; Legends . The Company may issue stock certificates or evidence the Participant’s interest by using a restricted book entry account with the Company’s transfer agent. A legend may be placed on any certificate or other document delivered to the Participant indicating restrictions on transferability of the shares of Restricted Stock pursuant to this Award Agreement or any other restrictions that the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, and any applicable federal or state securities laws or any stock exchange on which the shares of Stock are then listed or quoted.

9. Miscellaneous .

(a) Compliance with Laws . If the Company, in its sole discretion, determines that the listing upon any securities exchange or registration or qualification under any federal, state or local law or any foreign law of any shares to be issued pursuant to an Award is necessary or desirable, issuance of such shares shall not be made until such listing, registration or qualification shall have been completed.

(b) Incorporation of Plan . The shares of Restricted Stock are subject to the Plan and any interpretations by the Committee under the Plan, which are hereby incorporated into this Award Agreement by reference and made a part hereof. By the execution of this Award Agreement, the Participant acknowledges that the Plan document and the Plan prospectus, as in effect on the date of this Agreement, have been made available to the Participant for review. In the event of any conflict between the Plan and this Award Agreement, the Plan shall control.

(c) Administration, Interpretation, Etc . Any action taken or decision made by the Company, the Board or the Committee arising out of or in connection with the construction, administration, interpretation or effect of any provision of the Plan or this Award Agreement shall lie within its sole and absolute discretion, as the case may be, and shall be final, conclusive and binding on the Participant and all persons claiming under or through the Participant. By receipt of the shares of Restricted Stock or other benefit under the Plan, the Participant and each person claiming under or through the Participant shall be conclusively deemed to have indicated acceptance and ratification of, and consent to, any action taken under the Plan or this Award Agreement by the Company, the Board or the Committee.

(d) Amendment . This Award Agreement may be amended from time to time by the Committee, in its sole discretion, in any manner that the Committee deems necessary or appropriate; provided, however, that no such amendment shall adversely affect in a material manner any right of the Participant under the Award without the written consent of the Participant.

(e) Capital Changes and Adjustments . If any change is made to the outstanding shares of Stock or the capital structure of the Company, if required, the shares of Restricted Stock shall be adjusted in any manner as contemplated by Section 12 of the Plan.




Exhibit 10.2


(f) No Right of Employment . Nothing contained herein shall confer upon the Participant any right to continued employment by the Company or any of its Affiliates or interfere in any way with the right of the Company or any of its Affiliates, which is hereby reserved, to terminate the employment of the Participant at any time for any reason whatsoever.

(g) Rights as a Stockholder . Upon grant of the Award and subject to the restrictions contained in Sections 2, 3, 4, 5, 6 and 7, the Participant shall be the record owner of the shares of Restricted Stock and shall have all the rights of a stockholder of the Company with respect to the shares of Restricted Stock, including the right to vote the shares of Restricted Stock and receive all dividends and other distributions paid or made with respect thereto.

(h) Notices . Any notices necessary or required to be given under this Award Agreement: (i) to the Company shall be sufficiently given if in writing, and personally delivered to the Secretary of the Company or mailed to its principal office, 105 Norton Street, P.O. Box 271, Newark, New York 14513; or (ii) to the Participant shall be sufficiently given if in writing, and personally delivered or mailed by registered or certified mail, return receipt requested, postage prepaid, to the last known address of the Participant, or to such other address as the Participant shall have specified in writing to the Company.

(i) Successors and Assigns . This Award Agreement shall bind and inure to the benefit of the Company and the successors and assigns of the Company and to the Participant and to the Participant’s heirs, executors, administrators, successors and assigns.

(j) Governing Law . All questions pertaining to the interpretation, validity, enforcement and performance of this Award Agreement shall be construed in accordance with, and be governed by, the laws of the State of New York, without giving effect to the choice of law principles thereof.

(k) Participant Acknowledgement . By signing this Award Agreement, the Participant acknowledges that the Participant has received a copy of the Plan, has had an opportunity to review the Plan and this Award Agreement in their entirety, understands all provisions of the Plan and this Award Agreement, and agrees to be bound by, and to comply with, all the terms and provisions of the Plan and this Award Agreement.

(l) Counterparts . This Award Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which shall constitute one and the same agreement.

*    *    *    *    *





Exhibit 10.2



IN WITNESS WHEREOF, the Company has caused this Award Agreement to be executed effective as of the Date of Grant set forth above.
 
IEC ELECTRONICS CORP.
 
 
 
 
By:
 
 
 
[________]
 
 
 
 
Its:
President & Chief Executive Officer
 
 
 
 
Date:
 


ACCEPTANCE
 
I, ___________________, hereby certify that I have read and fully understand the foregoing Award Agreement. I hereby execute this Award Agreement to indicate my acceptance of the shares of Restricted Stock and my intent to comply with the terms thereof.

 
 
 
 
Participant
 
 
 
 
 
Street Address
 
 
 
 
 
 
City
State
Zip Code
 
 
 
 
 
Date:
 




Exhibit 10.3



IEC ELECTRONICS CORP.

2019 STOCK INCENTIVE PLAN
INCENTIVE STOCK OPTION AWARD AGREEMENT

    This Incentive Stock Option Award Agreement (this “ Award Agreement ”) is made and entered into as of [__________], 20__ (the “ Date of Grant ”), by and between IEC Electronics Corp. (the “Company”) and [_______________________] (the “ Participant ”). Capitalized terms not defined in this Award Agreement shall have the respective meanings given such terms by the IEC Electronics Corp. 2019 Stock Incentive Plan (the “ Plan ”).

1. Award . The Company hereby grants to the Participant an award of Incentive Stock Options (the “ Option ”) to purchase up to [_________] shares of Stock at an exercise price of $[______] per share (the “ Exercise Price ”) subject to the provisions of the Plan and to the terms and conditions of this Award Agreement. The Option is intended to be an “incentive stock option” as defined in Section 422 of the Code.
 
2. Vesting . Except as otherwise provided by the Participant’s employment agreement (if any), subject to the provisions of the Plan and this Award Agreement, and subject to the Participant’s continued service with the Company or any of its Affiliates through such date, [________] of the Option shall vest on [________] (each such date a “ Vesting Date ”).

3. Acceleration of Vesting . Notwithstanding the provisions of Section 2 above, the Option will immediately vest:

(a) in the event of a Change in Control if either:

(i) the employment of the Participant is terminated without Cause within two years of such Change in Control; or

(ii) the acquirer does not agree to assume or substitute the Option for similar awards on shares of acquirer’s common stock; or

(b) upon the occurrence of any other event or condition for which the Participant’s employment agreement (if any) provides for accelerated vesting.

4. Exercise .

(a) Prior to the expiration of the Option pursuant to the terms of this Award Agreement, the Participant may exercise the Option from time to time to the extent it has vested by tendering to the Company written notice of exercise (in the form attached to this Award Agreement, or such other form provided by the Company for such purpose), which notice may require the Participant to certify in a manner acceptable to the Company that the Participant is in compliance with the terms and conditions of the Plan and this Award Agreement (including Section 8 below), together with payment in full of the Exercise Price for the shares of Stock being acquired thereunder by any of the following methods, subject to the Committee’s discretion:
(i) cash, wire transfer or check made payable to the Company;




Exhibit 10.3


(ii) tendering (actually or by attestation) to the Company a number of previously acquired shares of Stock that have been held by the Participant for at least six months (or such shorter period, if any, determined by the Committee in consideration of applicable accounting standards) and that have a fair market value equal to the applicable portion of the Exercise Price being so paid;

(iii) authorizing a third party to sell, on behalf of the Participant, the appropriate number of shares of Stock otherwise issuable to the Participant upon exercise of the Option and to remit to the Company a sufficient portion of the sale proceeds to pay the entire Exercise Price and any tax withholding resulting from such exercise; or

(iv) any combination of the foregoing.
In the event the Option is exercised by any person or persons other than the Participant, the notice shall be accompanied by appropriate proof of the right of such person or persons to exercise the Option. In no event shall the Option be exercised for a fractional share of Stock.

(b) Upon exercise, the shares of Stock covered by the exercise of the Option (less the number of shares of Stock withheld to pay the exercise price pursuant to Section 4(a)(iii)) will be issued to the Participant on, or as soon as practicable after, the exercise date, with the appropriate legends, if any, affixed thereto. The issuance of shares of Stock upon exercise of the Option may be made by crediting the shares of Stock to an account for the benefit of the Participant or by such other permissible manner chosen by the Company

5. Expiration . Each vested Option is exercisable until 5:00 p.m. (Eastern Time) on the date that is seven years from the Date of Grant (the “ Expiration Date ”), unless terminated sooner in accordance with Section 7, or unless the Committee provides otherwise.

6. Restrictions on Transfer . The Option shall be exercisable during the Participant’s lifetime only by the Participant and may not be sold, exchanged, transferred, pledged, hypothecated, or otherwise disposed of, except by will or the laws of descent and distribution, and they shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation, or other disposition of the Option contrary to the provisions hereof, and the levy of any execution, attachment, or similar process upon the Option, shall be null and void and without effect.

7. Termination of Employment . Except as otherwise provided by the Participant’s employment agreement (if any), upon the Participant’s termination of employment with the Company and its Affiliates, the following provisions shall apply:

(a) Death . If the Participant’s termination of employment is on account of death, all rights in and to the Option granted pursuant to this Award Agreement which have not vested as described in Sections 2 and 3 shall be forfeited, and the Option, to the extent vested, may be exercised in whole or in part by the Participant’s designated beneficiary at any time on or before the earlier of (A) the Expiration Date or (B) the first anniversary of the date of such termination of employment.

(b) Disability . If the Participant’s termination of employment is on account of Disability, all rights in and to the Option granted pursuant to this Award Agreement which have not vested as described in Sections 2 and 3 shall be forfeited, and the Option, to the extent vested, may be exercised in whole or in part by the Participant at any time on or before the earlier of (A) the Expiration Date or (B) the first anniversary of the date of such termination of employment.



Exhibit 10.3


(c) Cause . If the Participant’s termination of employment is for Cause, all rights in and to the Option granted pursuant to this Award Agreement, whether vested or unvested as described in Sections 2 and 3, shall be forfeited on the date of such termination of employment.
 
(d) Other Reasons . If the Participant’s termination of employment is for any reason other than death, Disability or Cause, all rights in and to the Option granted pursuant to this Award Agreement which have not vested as described in Sections 2 and 3 shall be forfeited, and the Option, to the extent vested, may be exercised in whole or in part by the Participant at any time on or before the earlier of (A) the Expiration Date or (B) three months after the date of such termination of employment.

(e) Death after termination of employment . If the Participant’s termination of employment is for any reason other than death or for Cause, and the Participant dies after such termination of employment but before the date the Option must be exercised pursuant to this Section 7, all rights in and to the Option granted pursuant to this Award Agreement which have not vested as described in Sections 2 and 3 shall be forfeited, and the Option, to the extent vested on the date of the Participant’s death, may be exercised in whole or in part by the Participant’s designated beneficiary at any time on or before the earlier of (A) the Expiration Date or (B) the first anniversary of the date of death.

8. Detrimental Activities .

(a) The Committee may cancel, rescind, suspend, withhold or otherwise limit or restrict the Option at any time upon a determination by the Committee that the Participant is not in compliance with all applicable provisions of this Award Agreement and the Plan or that the Participant engaged in Detrimental Activity. “ Detrimental Activity ” shall include: (i) the rendering of services for any organization or engaging directly or indirectly in any business which is or becomes competitive with the Company or any Affiliate, or which organization of business, or the rendering of services to such organization or business, is or becomes otherwise prejudicial to in conflict with the interests of the Company or any Affiliate; (ii) the disclosure to anyone outside the Company or any of its Affiliates, or the use in other than the Company’s business, without prior written authorization from the Company, of any confidential information or material relating to the business of the Company or any of its Affiliates, acquired by the Participant either during or after employment with the Company or an Affiliate; (iii) activity that results in termination of the Participant’s employment for Cause; (iv) a violation of any rules, policies, procedures or guidelines of the Company or an Affiliate, including, but not limited to, the Company’s Code of Business Conduct and Ethics; (v) any attempt, directly or indirectly, to induce any employee of the Company or any Affiliate to be employed or perform services elsewhere or any attempt, directly or indirectly, to solicit the trade or business of any current or prospective customer, supplier or partner of the Company or any Affiliate; or (vi) any other conduct or act determined by the Board to be injurious, detrimental or prejudicial to any interest of the Company or any Affiliate.

(b) Notwithstanding the foregoing, nothing in Section 8(a) above: (i) prohibits the Participant from making reports of possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice and the Securities and Exchange Commission, in accordance with the provisions and rules of Section 21F of the Exchange Act, Section 806 of the Sarbanes-Oxley Act of 2002, or of any other whistleblower protection provisions of state or federal law or regulation, or (ii) requires notification or prior approval by the Company of any such report; provided that, the Participant is not authorized to disclose communications with counsel that were made for the purpose of receiving legal advice or that contain legal advice or that are protected by the attorney work product or similar privilege. Furthermore, the Participant shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose



Exhibit 10.3


of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.

9. Recoupment .
 
(a) Recoupment . As provided by Section 6.9 of the Plan, notwithstanding anything in the Plan or this Award Agreement, the Company will be entitled to the extent required by applicable law (including, without limitation, Section 10D of the Exchange Act and any regulations promulgated with respect thereto) or Exchange listing conditions, in each case as in effect from time to time, to recoup compensation of whatever kind paid under this Award Agreement by the Company at any time.

(b) Repayment of Gain; Setoff . If the Participant engages in Detrimental Activity prior to or during the six months after shares of Stock are issued pursuant to Section 4(b) above, such issuance may be rescinded within two years thereafter. In the event of any such rescission, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of the rescinded issuance, in such manner and on such terms and conditions as may be required, and the Company shall be entitled to setoff against the amount of any such gain any amount owed to the Participant by the Company or any Affiliate.

10. Withholding of Taxes . In order to exercise the Option, the Participant (or any other person or persons exercising the Option) shall make appropriate arrangements with the Company to the extent necessary for the satisfaction of all federal, state, local or foreign income or other tax withholding requirements, if any, applicable to the exercise of the Option.

11. Disqualifying Disposition . The Participant shall notify the Company in writing within 30 days of making a Disqualifying Disposition (as defined below) of any shares of Stock received pursuant to the exercise of the Option, and shall provide the Company with any information that the Company shall request concerning any such Disqualifying Disposition. “ Disqualifying Disposition ” means any disposition (including any sale) of the shares of Stock before the later of (a) the second anniversary of the Date of Grant and (b) the first anniversary of the date on which the Participant acquired such shares by exercising the Option, provided that such holding period requirements terminate upon the death of the Participant.

12. Miscellaneous .

(a) Compliance with Laws . If the Company, in its sole discretion, determines that the listing upon any securities exchange or registration or qualification under any federal, state or local law or any foreign law of any shares of Stock to be issued pursuant to the Option is necessary or desirable, issuance of such shares shall not be made until such listing, registration or qualification shall have been completed.

(b) Incorporation of Plan . The Option is subject to the Plan and any interpretations by the Committee under the Plan, which are hereby incorporated into this Award Agreement by reference and made a part hereof. By the execution of this Award Agreement, the Participant acknowledges that the Plan document and the Plan prospectus, as in effect on the date of this Agreement, have been made available to the Participant for review. In the event of any conflict between the Plan and this Award Agreement, the Plan shall control.

(c) Administration, Interpretation, Etc . Any action taken or decision made by the Company, the Board or the Committee arising out of or in connection with the construction, administration, interpretation or effect of any provision of the Plan or this Award Agreement shall lie within its sole and



Exhibit 10.3


absolute discretion, as the case may be, and shall be final, conclusive and binding on the Participant and all persons claiming under or through the Participant. By receipt of the Option or other benefit under the Plan, the Participant and each person claiming under or through the Participant shall be conclusively deemed to have indicated acceptance and ratification of, and consent to, any action taken under the Plan or this Award Agreement by the Company, the Board or the Committee.

(d) Amendment . This Award Agreement may be amended from time to time by the Committee, in its sole discretion, in any manner that the Committee deems necessary or appropriate; provided, however, that no such amendment shall adversely affect in a material manner any right of the Participant under the Option without the written consent of the Participant.

(e) Capital Changes and Adjustments . The Option shall be adjusted by the Committee at the same time as adjustments are made in accordance with Section 12 of the Plan in a manner similar to, and subject to, the same requirements under Section 12 of the Plan; provided, however, any adjustment shall be made in a manner that complies with Section 424(a) of the Code.

(f) No Right of Employment . Nothing contained herein shall confer upon the Participant any right to continued employment by the Company or any of its Affiliates or interfere in any way with the right of the Company or any of its Affiliates, which is hereby reserved, to terminate the employment of the Participant at any time for any reason whatsoever.

(g) No Stockholder Rights . Until the Participant is the holder of record of the shares of Stock issued upon exercise of the Option, the Participant shall have no rights of a stockholder of the Company with respect to the shares of Stock underlying the Option, and in particular shall not be entitled to vote the underlying shares of Stock or to receive any dividends paid with respect to the shares of Stock underlying the Option.

(h) Notices . Any notices necessary or required to be given under this Award Agreement: (i) to the Company shall be sufficiently given if in writing, and personally delivered to the Secretary of the Company or mailed to its principal office, 105 Norton Street, P.O. Box 271, Newark, New York 14513; or (ii) to the Participant shall be sufficiently given if in writing, and personally delivered or mailed by registered or certified mail, return receipt requested, postage prepaid, to the last known address of the Participant, or to such other address as the Participant shall have specified in writing to the Company.

(i) Successors and Assigns . This Award Agreement shall bind and inure to the benefit of the Company and the successors and assigns of the Company and to the Participant and to the Participant’s heirs, executors, administrators, successors and assigns.

(j) Governing Law . All questions pertaining to the interpretation, validity, enforcement and performance of this Award Agreement shall be construed in accordance with, and be governed by, the laws of the State of New York, without giving effect to the choice of law principles thereof.

(k) Section 409A . The Option granted under this Award Agreement is intended to be exempt from the requirements of Section 409A and the Plan and this Award Agreement shall be interpreted and administered in accordance with such intention. Notwithstanding the foregoing, the Company makes no representations that the Option is exempt from Section 409A, and in no event shall the Company or any Affiliate be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by a Participant on account of a violation of Section 409A.



Exhibit 10.3


(l) Participant Acknowledgment . By signing this Award Agreement, the Participant acknowledges that the Participant has received a copy of the Plan, has had an opportunity to review the Plan and this Award Agreement in their entirety, understands all provisions of the Plan and this Award Agreement, and agrees to be bound by, and to comply with, all the terms and provisions of the Plan and this Award Agreement.

(m) Counterparts . This Award Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which shall constitute one and the same agreement.

*    *    *    *    *




Exhibit 10.3



IN WITNESS WHEREOF, the Company has caused this Award Agreement to be executed effective as of the Date of Grant set forth above.
 
IEC ELECTRONICS CORP.
 
 
 
 
By:
 
 
 
[________]
 
Its:
President & CEO
 
 
 
 
Date:
 


ACCEPTANCE
 
I, ___________________, hereby certify that I have read and fully understand the foregoing Award Agreement. I acknowledge that I have been apprised that it is the intent of the Company that Participants obtain and retain an equity interest in the Company. I hereby execute this Award Agreement to indicate my acceptance of the Option and my intent to comply with the terms thereof.


 
 
 
 
Participant
 
 
 
 
 
Street Address
 
 
 
 
 
 
City
State
Zip Code
 
 
 
 
 
Date:
 




Exhibit 10.3



_____________, 20___
IEC Electronics Corp.
Attention: Secretary
105 Norton Street
Newark, NY 14513


Dear Sir:

This is to notify you that I hereby elect to exercise the Option granted to me under the Incentive Stock Option Award Agreement (the “Award Agreement”), dated ____________________, 20__, issued to me pursuant to the 2019 Stock Incentive Plan (the “Plan”) with respect to ________ shares of common stock of IEC Electronics Corp. (the “ Company ”). The Exercise Price pursuant to the Award Agreement as adjusted (if applicable) is $____________ per share or $__________ in the aggregate.

In payment of the full Exercise Price, I enclose (please complete as appropriate):

a. my check payable to IEC Electronics Corp. in the amount of $__________.

b.
__________ shares of common stock of the Company owned by me for at least six months, free of any liens or encumbrances and having a fair market value of $_________.

c.
an authorization letter which gives irrevocable instructions to the Company to deliver the stock certificates representing the shares for which the option is being exercised directly to ______________ (name and address of broker) together with a copy of the instructions to _______________ (name of broker) to sell such shares and promptly deliver to the Company the portion of the proceeds equal to the total purchase price and withholding taxes due, if any.

I hereby certify that I am in compliance with the terms and conditions of the Plan and the Award Agreement and, in particular, that I have not engaged in any Detrimental Activity as defined in Section 8 of the Award Agreement. I understand, acknowledge and agree that in the event I engage in Detrimental Activity during the period specified in Section 9(b) of the Award Agreement, the exercise of the Option may be rescinded by the Company and I may become obligated to pay the Company the amount of any gain realized or payment received as a result of the rescinded exercise, all as set forth in Section 9 of the Award Agreement.

Very truly yours,
 
Participant’s Signature




Exhibit 10.4


IEC ELECTRONICS CORP.

2019 STOCK INCENTIVE PLAN
DIRECTOR RESTRICTED STOCK AWARD AGREEMENT
This Director Restricted Stock Award Agreement (this “ Award Agreement ”) is made and entered into as of [_______________], 20__ (the “ Date of Grant ”), by and between IEC Electronics Corp. (the “ Company ”) and ___________________ (the “ Director ”). Capitalized terms not defined in this Award Agreement shall have the respective meanings given such terms by the IEC Electronics Corp. 2019 Stock Incentive Plan (the “ Plan ”).
1. Award . The Company hereby grants to the Director an Award (the “ Award ”) of Restricted Stock of [________] shares of Stock (the “ Restricted Stock ”), subject to the provisions of the Plan and to the terms and conditions of this Award Agreement.

2. Vesting and Payment . Subject to the provisions of the Plan and this Award Agreement, and subject to the Director’s continued membership on the Board through such date, the shares of Restricted Stock will vest as follows: [________] (each such date a “ Vesting Date ”).

3. Lapse of Restrictions and Acceleration of Vesting . Notwithstanding the provisions of Section 2 above, the restrictions set forth in this Award Agreement will immediately lapse and the shares of Restricted Stock will immediately vest upon the occurrence of any of the following events prior to the Vesting Date: (a) the Director’s death; (b) the Director’s Disability; or (c) a Change in Control if either (i) the service of the Director is terminated or (ii) the acquirer does not agree to assume or substitute the shares of Restricted Stock for similar awards on shares of acquirer’s common stock.

4. Restrictions on Transfer . Except as otherwise provided in this Award Agreement, until the shares of Restricted Stock vest, the shares of Restricted Stock may not be sold, exchanged, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent and distribution, and they shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation, or other disposition of the shares of Restricted Stock contrary to the provisions hereof, and the levy of any execution, attachment, or similar process upon the shares of Restricted Stock, shall be null and void and without effect.

5. Termination of Services; Detrimental Activities .

(a) All rights in and to any and all shares of Restricted Stock granted pursuant to this Award Agreement, which have not vested as described in Section 2 or 3 above, shall be forfeited upon: (i) the Director’s termination of Board membership for any reason, other than the Director’s death or Disability or a Change in Control; or (ii) a determination by the Board that the Director engaged in Detrimental Activity. “ Detrimental Activity ” shall include: (A) the rendering of services for any organization or engaging directly or indirectly in any business which is or becomes competitive with the Company or any Affiliate, or which organization or business, or the rendering of services to such organization or business, is or becomes otherwise prejudicial to or in conflict with the interests of the Company or any Affiliate; (B) the disclosure to anyone outside the Company or any of its Affiliates, or the use in other than the Company’s business, without prior written authorization from the Company, of any confidential information or material relating to the business of the Company or any of its Affiliates, acquired by the Director either during or after service to the Company or an Affiliate; (C) a violation of any rules, policies, procedures or guidelines of the Company or an Affiliate,



Exhibit 10.4


including, but not limited to, the Company’s Code of Business Conduct and Ethics; (D) any attempt, directly or indirectly, to induce any employee of the Company or any Affiliate to be employed or perform services elsewhere or any attempt, directly or indirectly, to solicit the trade or business of any current or prospective customer, supplier or partner of the Company or any Affiliate; or (E) any other conduct or act determined by the Board to be injurious, detrimental or prejudicial to any interest of the Company or any Affiliate.

(b) Permissible Actions . Notwithstanding the foregoing, nothing in Section 5(a) above: (i) prohibits the Director from making reports of possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice and the Securities Exchange Commission, in accordance with the provisions and rules of Section 21F of the Exchange Act or of any other whistleblower protection provisions of state or federal law or regulation, or (ii) requires notification or prior approval by the Company of any such report; provided that, the Director is not authorized to disclose communications with counsel that were made for the purpose of receiving legal advice or that contain legal advice or that are protected by the attorney work product or similar privilege. Furthermore, the Director shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.

6. Stock Certificates .

(a) Certificate; Book Entry . The Company, in its discretion, shall issue the shares of Restricted Stock either (i) in certificate form or (ii) in book entry form, registered in the name of the Director, with legends, or notations, as applicable, referring to the terms, conditions and restrictions applicable to the shares of Restricted Stock.

(b) Legend . The Director agrees that any certificate issued for the shares of Restricted Stock prior to the lapse of any outstanding restrictions relating thereto shall be inscribed with the following legend, and any book entry shall bear a similar notation:

THIS CERTIFICATE AND THE SHARES OF STOCK REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS, INCLUDING FORFEITURE PROVISIONS AND RESTRICTIONS AGAINST TRANSFER (THE “RESTRICTIONS”), CONTAINED IN THE IEC ELECTRONICS CORP. 2019 STOCK INCENTIVE PLAN, AND IN A DIRECTOR RESTRICTED STOCK AWARD AGREEMENT ENTERED INTO BETWEEN THE REGISTERED OWNER AND THE COMPANY. ANY ATTEMPT TO DISPOSE OF THESE SHARES IN CONTRAVENTION OF THE RESTRICTIONS, INCLUDING BY WAY OF SALE, ASSIGNMENT, TRANSFER, PLEDGE, HYPOTHECATION OR OTHERWISE, SHALL BE NULL AND VOID AND WITHOUT EFFECT.
(c) Custody . The Company may retain physical custody of the certificates representing the shares of Restricted Stock, or control of the applicable book entry account, until all of the restrictions on transfer pursuant to this Award Agreement lapse or shall have been removed; and the Director shall not retain physical custody of any certificates representing unvested shares of Restricted Stock issued to the Director.

(d) Removal of Legend . Upon the lapse of restrictions relating to any shares of Restricted Stock, the Company shall, as applicable, either remove the notations on any such shares of Restricted Stock



Exhibit 10.4


issued in book-entry form or deliver to the Director or the Director’s personal representative a stock certificate representing a number of shares of Stock, free of the restrictive legend described above, equal to the number of shares of Restricted Stock with respect to which such restrictions have lapsed. If certificates representing such shares of Restricted Stock shall have heretofore been delivered to the Director, such certificates shall be returned to the Company, complete with any necessary signatures or instruments of transfer prior to the issuance by the Company of such unlegended shares of Stock.

(e) Forfeited Shares . Any shares of Restricted Stock forfeited pursuant to this Award Agreement shall be transferred to, and reacquired by, the Company without payment of any consideration by the Company, and neither the Company nor any of the Director’s successors, heirs, assigns or personal representatives shall thereafter have any further rights or interests in such shares. If certificates for any such shares of Restricted Stock containing restrictive legends shall have theretofore been delivered to the Director (or the Director’s legatees or personal representative), such certificates shall be returned to the Company, complete with any necessary signatures or instruments of transfer.

(f) Stock Power; Power of Attorney . Concurrently with the execution and delivery of this Award Agreement, the Director shall deliver to the Company an executed stock power in the form attached hereto as Exhibit A, in blank, with respect to such shares of Restricted Stock. The Director, by acceptance of the Award, shall be deemed to appoint, and does so appoint by execution of this Award Agreement, the Company and each of its authorized representatives as the Director’s attorney(s)-in-fact to effect any transfer of forfeited shares of Restricted Stock.

7. Miscellaneous .

(a) Compliance with Laws . If the Company, in its sole discretion, determines that the listing upon any securities exchange or registration or qualification under any federal, state or local law or any foreign law of any shares to be issued pursuant to an Award is necessary or desirable, issuance of such shares shall not be made until such listing, registration or qualification shall have been completed.

(b) Incorporation of Plan . The shares of Restricted Stock are subject to the Plan and any interpretations by the Board under the Plan, which are hereby incorporated into this Award Agreement by reference and made a part hereof. By the execution of this Award Agreement, the Director acknowledges that the Plan document and the Plan prospectus, as in effect on the date of this Agreement, have been made available to the Director for review. In the event of any conflict between the Plan and this Award Agreement, the Plan shall control.

(c) Administration, Interpretation, Etc . Any action taken or decision made by the Company or the Board arising out of or in connection with the construction, administration, interpretation or effect of any provision of the Plan or this Award Agreement shall lie within its sole and absolute discretion, as the case may be, and shall be final, conclusive and binding on the Director and all persons claiming under or through the Director. By receipt of the shares of Restricted Stock or other benefit under the Plan, the Director and each person claiming under or through the Director shall be conclusively deemed to have indicated acceptance and ratification of, and consent to, any action taken under the Plan or this Award Agreement by the Company or the Board.

(d) Amendment . This Award Agreement may be amended from time to time by the Board, in its sole discretion, in any manner that the Board deems necessary or appropriate; provided, however, that no such amendment shall adversely affect in a material manner any right of the Director under the Award without the written consent of the Director.



Exhibit 10.4


(e) Shares Issued Upon Changes in Capitalization . The restrictions imposed under this Award Agreement shall apply as well to all shares or other securities issued in respect of the shares of Restricted Stock in connection with any stock split, stock dividend, stock distribution, recapitalization, reclassification, merger, consolidation or reorganization.

(f) Rights as a Stockholder . Upon grant of the Award and subject to the restrictions contained in Sections 2, 3, 4, 5 and 6, the Director shall be the record owner of the shares of Restricted Stock and shall have all the rights of a stockholder of the Company with respect to the shares of Restricted Stock, including the right to vote the shares of Restricted Stock and receive all dividends and other distributions paid or made with respect thereto.

(g) Notices . Any notices necessary or required to be given under this Award Agreement: (i) to the Company shall be sufficiently given if in writing, and personally delivered to the Secretary of the Company or mailed to its principal office, 105 Norton Street, P.O. Box 271, Newark, New York 14513; or (ii) to the Director shall be sufficiently given if in writing, and personally delivered or mailed by registered or certified mail, return receipt requested, postage prepaid, to the last known address of the Director, or to such other address as the Director shall have specified in writing to the Company.

(h) Successors and Assigns . This Award Agreement shall bind and inure to the benefit of the Company and the successors and assigns of the Company and to the Director and to the Director’s heirs, executors, administrators, successors and assigns.

(i) Governing Law . All questions pertaining to the interpretation, validity, enforcement and performance of this Award Agreement shall be construed in accordance with, and be governed by, the laws of the State of New York, without giving effect to the choice of law principles thereof.

(j) Director Acknowledgement . By signing the Award Agreement, the Director acknowledges that the Director has received a copy of the Plan, has had an opportunity to review the Plan and this Award Agreement in their entirety, understands all provisions of the Plan and this Award Agreement, and agrees to be bound by, and to comply with, all the terms and provisions of the Plan and this Award Agreement.

(k) Counterparts . This Award Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which shall constitute one and the same agreement.

*    *    *    *    *



Exhibit 10.4



IN WITNESS WHEREOF, the Company has caused this Award Agreement to be executed effective as of the Date of Grant set forth above.
 
IEC ELECTRONICS CORP.
 
 
 
 
By:
 
 
 
[________]
 
 
 
 
Its:
President & Chief Executive Officer
 
 
 
 
Date:
 


ACCEPTANCE
 
I, ___________________, hereby certify that I have read and fully understand the foregoing Award Agreement. I hereby execute this Award Agreement to indicate my acceptance of the shares of Restricted Stock and my intent to comply with the terms thereof.
 
 
 
 
Director
 
 
 
 
 
Street Address
 
 
 
 
 
 
City
State
Zip Code
 
 
 
 
 
Date:
 




Exhibit 10.4




EXHIBIT A

STOCK POWER

For Value Received, the undersigned hereby sells, assigns and
transfers unto IEC Electronics Corp. (the “Corporation”)
__________ Shares of the Common Stock of the Corporation standing in my name on the books of said Corporation represented by Certificate(s) No(s)._______, and does hereby
irrevocably constitute and appoint
__________________________________________________________
attorney to transfer the said stock on the books of said Corporation
with full power of substitution in the premises.

Dated:__________________
_______________________________________                                                                    




Exhibit 10.5



IEC ELECTRONICS CORP.

2019 STOCK INCENTIVE PLAN
RESTRICTED STOCK UNIT AWARD AGREEMENT

This Restricted Stock Unit Award Agreement (this “ Award Agreement ”) is made and entered into as of [_______________], 20__ (the “ Date of Grant ”), by and between IEC Electronics Corp. (the “ Company ”) and ___________________ (the “ Participant ”). Capitalized terms not defined in this Award Agreement shall have the respective meanings given such terms by the IEC Electronics Corp. 2019 Stock Incentive Plan (the “ Plan ”).

1. Award . The Company hereby grants to the Participant an Award (the “ Award ”) of Restricted Stock Units (the “ RSUs ”) covering [____________] shares of Stock, subject to the provisions of the Plan and to the terms and conditions of this Award Agreement.

2. Vesting and Payment . Except as otherwise provided by the Participant’s employment agreement (if any), subject to the provisions of the Plan and this Award Agreement, and subject to the Participant’s continued service with the Company or any of its Affiliates through such date, the RSUs will vest on [________] (the “ Vesting Date ”). Upon vesting, each vested RSU will convert at that time into the right to receive one share of Stock, which, less the number of shares of Stock (if any) withheld to satisfy tax withholding pursuant to Section 7 below, will be issued to the Participant on, or as soon as practicable after, the Vesting Date, but no later than the later of (i) December 31 of the year in which the Vesting Date occurs, and (ii) the 15th day of the third calendar month following the Vesting Date.

3. Acceleration of Vesting and Payment .

(a) Notwithstanding the provisions of Section 2 above, the RSUs will immediately vest upon the occurrence of any of the following events prior to the Vesting Date: (i) the Participant’s death; (ii) the Participant’s Disability; (iii) a Change in Control if either (A) the employment of the Participant is terminated without Cause within two years of such Change in Control or (B) the acquirer does not agree to assume or substitute the RSUs for similar awards on shares of acquirer’s common stock; or (iv) the occurrence of any other event or condition for which the Participant’s employment agreement (if any) provides for accelerated vesting.

(b) In the event of accelerated vesting pursuant to Section 3(a), the number of shares of Stock from the conversion of the RSUs, less the number of shares of Stock (if any) withheld to satisfy tax withholding pursuant to Section 7 below, will be paid to the Participant at the time specified by Section 2 above as if no acceleration had occurred, unless otherwise specifically provided by the Participant’s employment agreement (if any), in which case the vested RSUs shall be paid at the time specified by the Participant’s employment agreement. Notwithstanding the foregoing, in the event of a Change in Control that satisfies Section 3(a)(iii) above that is a “change in ownership,” a “change in effective control” or a “change in ownership of a substantial portion of the assets” of the Company, each as defined by Section 409A, the number of shares of Stock from the conversion of the RSUs, less the number of shares of Stock (if any) withheld to satisfy tax withholding pursuant to Section 7 below, will be issued no later than 30 days after such Change in Control so long as such payment is permissible under Section 409A.

4. Restrictions on Transfer . Except as otherwise provided in this Award Agreement, until the RSUs vest and are paid in shares of Stock, the RSUs and underlying shares of Stock may not be sold,



Exhibit 10.5


exchanged, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent and distribution, and they shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation, or other disposition of the RSUs or underlying shares of Stock contrary to the provisions hereof, and the levy of any execution, attachment, or similar process upon the RSUs, shall be null and void and without effect.

5. Termination of Employment; Detrimental Activities .

(a) Except as otherwise provided by the Participant’s employment agreement (if any), all rights in and to any and all RSUs granted pursuant to this Award Agreement, and to any shares of Stock into which they would convert, which have not vested as described in Section 2 or 3 above, shall be forfeited upon: (i) the Participant’s termination of employment with the Company and its Affiliates for any reason, whether with or without Cause, other than the Participant’s death or Disability or a Change in Control; or (ii) a determination by the Committee that the Participant engaged in Detrimental Activity. “ Detrimental Activity ” shall include: (A) the rendering of services for any organization or engaging directly or indirectly in any business which is or becomes competitive with the Company or any Affiliate, or which organization or business, or the rendering of services to such organization or business, is or becomes otherwise prejudicial to or in conflict with the interests of the Company or any Affiliate; (B) the disclosure to anyone outside the Company or any of its Affiliates, or the use in other than the Company’s business, without prior written authorization from the Company, of any confidential information or material relating to the business of the Company or any of its Affiliates, acquired by the Participant either during or after employment with the Company or an Affiliate; (C) activity that results in termination of the Participant’s employment for Cause; (D) a violation of any rules, policies, procedures or guidelines of the Company or an Affiliate, including, but not limited to, the Company’s Code of Business Conduct and Ethics; (E) any attempt, directly or indirectly, to induce any employee of the Company or any Affiliate to be employed or perform services elsewhere or any attempt, directly or indirectly, to solicit the trade or business of any current or prospective customer, supplier or partner of the Company or any Affiliate; or (F) any other conduct or act determined by the Board to be injurious, detrimental or prejudicial to any interest of the Company or any Affiliate.

(b) Permissible Actions . Notwithstanding the foregoing, nothing in Section 5(a) above: (i) prohibits the Participant from making reports of possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice and the Securities Exchange Commission, in accordance with the provisions and rules of Section 21F of the Exchange Act, Section 806 of the Sarbanes-Oxley Act of 2002, or of any other whistleblower protection provisions of state or federal law or regulation, or (ii) requires notification or prior approval by the Company of any such report; provided that, the Participant is not authorized to disclose communications with counsel that were made for the purpose of receiving legal advice or that contain legal advice or that are protected by the attorney work product or similar privilege. Furthermore, the Participant shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.

6. Recoupment .

(a) Recoupment . As provided by Section 6.9 of the Plan, notwithstanding anything in the Plan or this Award Agreement, the Company will be entitled to the extent required by applicable law (including, without limitation, Section 10D of the Exchange Act and any regulations promulgated with respect



Exhibit 10.5


thereto) or Exchange listing conditions, in each case as in effect from time to time, to recoup compensation of whatever kind paid under this Award Agreement by the Company at any time.

(b) Repayment of Gain; Setoff . If the Participant engages in Detrimental Activity prior to or during the six months after shares of Stock are issued pursuant to Section 2 or 3 above, such issuance may be rescinded within two years thereafter. In the event of any such rescission, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of the rescinded issuance in such manner and on such terms and conditions as may be required, and the Company shall be entitled to setoff against the amount of any such gain any amount owed to the Participant by the Company or any Affiliate.

7. Withholding of Taxes . The Company and its Affiliates shall have the right, in its discretion, to withhold cash from the Participant’s remuneration or deduct shares of Stock that would otherwise be distributed pursuant to this Award Agreement from any payment made under this Award Agreement in satisfaction of the federal, state, local or foreign income or other taxes required by law to be withheld with respect to such payment (or such higher amount that would not have an adverse tax effect). Shares of Stock tendered as payment of required tax withholding shall be valued at the fair market value of the Company’s Stock on the date such tax withholding obligation arises. It shall be a condition to the obligation of the Company to issue shares of Stock or other property, or any combination thereof, upon payment of the Award, that the Participant pay to the Company or an Affiliate, upon its demand, such amount as may be requested by the Company or the Affiliate for the purpose of satisfying any liability to withhold federal, state, local or foreign income or other taxes. If the amount requested is not paid, the Company may refuse to issue or pay shares of Stock or other property, or any combination thereof.
 
8. Miscellaneous .

(a) Compliance with Laws . If the Company, in its sole discretion, determines that the listing upon any securities exchange or registration or qualification under any federal, state or local law or any foreign law of any shares to be issued pursuant to an Award is necessary or desirable, issuance of such shares shall not be made until such listing, registration or qualification shall have been completed.

(b) Issuance of Stock . The issuance of shares of Stock from the conversion of RSUs may be made by crediting the shares of Stock to an account for the benefit of the Participant or by such other permissible manner chosen by the Company.

(c) Incorporation of Plan . The RSUs are subject to the Plan and any interpretations by the Committee under the Plan, which are hereby incorporated into this Award Agreement by reference and made a part hereof. By the execution of this Award Agreement, the Participant acknowledges that the Plan document and the Plan prospectus, as in effect on the date of this Agreement, have been made available to the Participant for review. In the event of any conflict between the Plan and this Award Agreement, the Plan shall control.

(d) Administration, Interpretation, Etc . Any action taken or decision made by the Company, the Board or the Committee arising out of or in connection with the construction, administration, interpretation or effect of any provision of the Plan or this Award Agreement shall lie within its sole and absolute discretion, as the case may be, and shall be final, conclusive and binding on the Participant and all persons claiming under or through the Participant. By receipt of the RSUs or other benefit under the Plan, the Participant and each person claiming under or through the Participant shall be conclusively deemed to



Exhibit 10.5


have indicated acceptance and ratification of, and consent to, any action taken under the Plan or this Award Agreement by the Company, the Board or the Committee.

(e) Amendment . This Award Agreement may be amended from time to time by the Committee, in its sole discretion, in any manner that the Committee deems necessary or appropriate; provided, however, that no such amendment shall adversely affect in a material manner any right of the Participant under the Award without the written consent of the Participant.

(f) Capital Changes and Adjustments . The RSUs shall be adjusted by the Committee at the same time as adjustments are made in accordance with Section 12 of the Plan in a manner similar to, and subject to, the same requirements under Section 12 of the Plan.

(g) No Right of Employment . Nothing contained herein shall confer upon the Participant any right to continued employment by the Company or any of its Affiliates or interfere in any way with the right of the Company or any of its Affiliates, which is hereby reserved, to terminate the employment of the Participant at any time for any reason whatsoever.

(h) No Stockholder Rights . Until the shares of Stock from the payment of the RSUs have been issued to the Participant, the Participant shall have no rights of a stockholder of the Company with respect to the shares of Stock underlying the RSUs, and in particular shall not be entitled to vote the underlying shares of Stock or to receive any dividends or dividend equivalents paid or made with respect to the shares of Stock underlying the RSUs.

(i) Notices . Any notices necessary or required to be given under this Award Agreement: (i) to the Company shall be sufficiently given if in writing, and personally delivered to the Secretary of the Company or mailed to its principal office, 105 Norton Street, P.O. Box 271, Newark, New York 14513; or (ii) to the Participant shall be sufficiently given if in writing, and personally delivered or mailed by registered or certified mail, return receipt requested, postage prepaid, to the last known address of the Participant, or to such other address as the Participant shall have specified in writing to the Company.

(j) Successors and Assigns . This Award Agreement shall bind and inure to the benefit of the Company and the successors and assigns of the Company and to the Participant and to the Participant’s heirs, executors, administrators, successors and assigns.

(k) Governing Law . All questions pertaining to the interpretation, validity, enforcement and performance of this Award Agreement shall be construed in accordance with, and be governed by, the laws of the State of New York, without giving effect to the choice of law principles thereof.

(l) Section 409A . The RSUs granted under this Award Agreement are intended to comply with the requirements of Section 409A and the Plan and this Award Agreement shall be interpreted and administered in accordance with such intention. Notwithstanding the foregoing, the Company makes no representations that the RSUs comply with Section 409A, and in no event shall the Company or any Affiliate be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by a Participant on account of non-compliance with Section 409A. References to a Participant’s “termination of employment” and similar terms used in this Award Agreement mean, to the extent necessary to comply with Section 409A, the date that the Participant first incurs a “separation from service” within the meaning of Section 409A. Notwithstanding anything in this Award Agreement to the contrary, if at the time of the Participant’s separation from service, the Participant is a “specified employee” for purposes of Section 409A, and the payment of the RSUs under this Award Agreement as a result of such separation from service is



Exhibit 10.5


required to be delayed by six months pursuant to Section 409A, then the Company will make such payment on the date that is the first day of the seventh month following the Participant’s separation from service.

(m) Participant Acknowledgement . By signing the Award Agreement, the Participant acknowledges that Participant has received a copy of the Plan, has had an opportunity to review the Plan and this Award Agreement in their entirety, understands all provisions of the Plan and this Award Agreement, and agrees to be bound by, and to comply with, all the terms and provisions of the Plan and this Award Agreement.

(n) Counterparts . This Award Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which shall constitute one and the same agreement.

*    *    *    *    *



Exhibit 10.5



IN WITNESS WHEREOF, the Company has caused this Award Agreement to be executed effective as of the Date of Grant set forth above.
 
IEC ELECTRONICS CORP.
 
 
 
 
By:
 
 
 
Chair, Compensation Committee
 
 
 
 
Date:
 


ACCEPTANCE
 
I, ___________________, hereby certify that I have read and fully understand the foregoing Award Agreement. I hereby execute this Award Agreement to indicate my acceptance of the RSUs and my intent to comply with the terms thereof.
 
 
 
 
Participant
 
 
 
 
 
Street Address
 
 
 
 
 
 
City
State
Zip Code
 
 
 
 
 
Date:
 




Exhibit 10.6



IEC ELECTRONICS CORP.

2019 STOCK INCENTIVE PLAN
PERFORMANCE RESTRICTED STOCK UNIT AWARD AGREEMENT

This Performance Restricted Stock Unit Award Agreement (this “ Award Agreement ”) is made and entered into as of [_______________], 20__ (the “ Date of Grant ”), by and between IEC Electronics Corp. (the “ Company ”) and ___________________ (the “ Participant ”). Capitalized terms not defined in this Award Agreement shall have the respective meanings given such terms by the IEC Electronics Corp. 2019 Stock Incentive Plan (the “ Plan ”).

1. Award . The Company hereby grants to the Participant an Award (the “ Award ”) of Restricted Stock Units (the “ PSUs ”) covering [____________] shares of Stock, subject to the provisions of the Plan and to the terms and conditions of this Award Agreement.

2. Vesting and Payment . Except as otherwise provided by the Participant’s employment agreement (if any), subject to the provisions of the Plan and this Award Agreement, and subject to the Participant’s continued service with the Company or any of its Affiliates through the end of the Performance Period, the number of PSUs that will vest shall be based on the level of achievement of the performance goal(s) set forth on Exhibit A to this Award Agreement for the Performance Period set forth on Exhibit A, rounded to the nearest whole PSU. Upon vesting, each vested PSU will convert at that time into the right to receive one share of Stock, which, less the number of shares of Stock (if any) withheld to satisfy tax withholding pursuant to Section 7 below, will be issued to the Participant no later than the later of (i) December 31 of the year in which the Performance Period ends, and (ii) the 15th day of the third calendar month following the last day of the Performance Period.

3. Acceleration of Vesting and Payment .
 
(a) Notwithstanding the provisions of Section 2 above and Exhibit A, the PSUs will immediately vest upon the occurrence of any of the following events prior to the Vesting Date: (i) the Participant’s death; (ii) the Participant’s Disability; (iii) a Change in Control if either (A) the employment of the Participant is terminated without Cause within two years of such Change in Control or (B) the acquirer does not agree to assume or substitute the PSUs for similar awards on shares of acquirer’s common stock; or (iv) the occurrence of any other event or condition for which the Participant’s employment agreement (if any) provides for accelerated vesting. In the event of accelerated vesting due to (i), (ii) or (iv) above, the number of PSUs that shall vest and convert into the right to receive shares of Stock shall be equal to the target level of performance under Exhibit A. In the event of accelerated vesting due to (iii) above, the number of PSUs that shall vest and convert into the right to receive shares of Stock shall be based upon the degree of performance attainment through the date of such Change in Control or associated termination of employment without Cause, as applicable, with such amount either paid in full or paid pro rata based on the period of time elapsed in the Performance Period as of the applicable date, as determined by the Committee in its sole discretion.

(b) In the event of accelerated vesting pursuant to Section 3(a), the number of shares of Stock from the conversion of the PSUs, less the number of shares of Stock (if any) withheld to satisfy tax withholding pursuant to Section 7 below, will be paid to the Participant at the time specified by Section 2 above as if no acceleration had occurred, unless otherwise specifically provided by the Participant’s employment agreement (if any), in which case the PSUs that vest shall be paid in the amount and at the time



Exhibit 10.6


specified by the Participant’s employment agreement. Notwithstanding the foregoing, in the event of a Change in Control that satisfies Section 3(a)(iii) above that is a “change in ownership,” a “change in effective control” or a “change in ownership of a substantial portion of the assets” of the Company, each as defined by Section 409A, the number of shares of Stock from the conversion of the PSUs, less the number of shares of Stock (if any) withheld to satisfy tax withholding pursuant to Section 7 below, will be issued no later than 30 days after such Change in Control so long as such payment is permissible under Section 409A.

4. Restrictions on Transfer . Except as otherwise provided in this Award Agreement, until the PSUs vest and are paid in shares of Stock, the PSUs and underlying shares of Stock may not be sold, exchanged, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent and distribution, and they shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation, or other disposition of the PSUs or underlying shares of Stock contrary to the provisions hereof, and the levy of any execution, attachment, or similar process upon the PSUs, shall be null and void and without effect.

5. Forfeiture; Termination of Employment; Detrimental Activities .

(a) Except as otherwise provided by the Participant’s employment agreement (if any), all rights in and to any and all PSUs granted pursuant to this Award Agreement, and to any shares of Stock into which they would convert, which have not vested as described in Section 2 or 3 above, shall be forfeited: (i) if the performance targets for the Performance Period are not met; (ii) upon the Participant’s termination of employment with the Company and its Affiliates for any reason, whether with or without Cause, other than the Participant’s death or Disability or a Change in Control; or (iii) upon a determination by the Committee that the Participant engaged in Detrimental Activity. “ Detrimental Activity ” shall include: (A) the rendering of services for any organization or engaging directly or indirectly in any business which is or becomes competitive with the Company or any Affiliate, or which organization or business, or the rendering of services to such organization or business, is or becomes otherwise prejudicial to or in conflict with the interests of the Company or any Affiliate; (B) the disclosure to anyone outside the Company or any of its Affiliates, or the use in other than the Company’s business, without prior written authorization from the Company, of any confidential information or material relating to the business of the Company or any of its Affiliates, acquired by the Participant either during or after employment with the Company or an Affiliate; (C) activity that results in termination of the Participant’s employment for Cause; (D) a violation of any rules, policies, procedures or guidelines of the Company or an Affiliate, including, but not limited to, the Company’s Code of Business Conduct and Ethics; (E) any attempt, directly or indirectly, to induce any employee of the Company or any Affiliate to be employed or perform services elsewhere or any attempt, directly or indirectly, to solicit the trade or business of any current or prospective customer, supplier or partner of the Company or any Affiliate; or (F) any other conduct or act determined by the Board to be injurious, detrimental or prejudicial to any interest of the Company or any Affiliate.

(b) Permissible Actions . Notwithstanding the foregoing, nothing in Section 5(a) above: (i) prohibits the Participant from making reports of possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice and the Securities Exchange Commission, in accordance with the provisions and rules of Section 21F of the Exchange Act, Section 806 of the Sarbanes-Oxley Act of 2002, or of any other whistleblower protection provisions of state or federal law or regulation, or (ii) requires notification or prior approval by the Company of any such report; provided that, the Participant is not authorized to disclose communications with counsel that were made for the purpose of receiving legal advice or that contain legal advice or that are protected by the attorney work product or similar privilege. Furthermore, the Participant shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a



Exhibit 10.6


federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.
  
6. Recoupment .

(a) Recoupment . As provided by Section 6.9 of the Plan, notwithstanding anything in the Plan or this Award Agreement, the Company will be entitled to the extent required by applicable law (including, without limitation, Section 10D of the Exchange Act and any regulations promulgated with respect thereto) or Exchange listing conditions, in each case as in effect from time to time, to recoup compensation of whatever kind paid under this Award Agreement by the Company at any time.

(b) Repayment of Gain; Setoff . If the Participant engages in Detrimental Activity prior to or during the six months after shares of Stock are issued pursuant to Section 2 or 3 above, such issuance may be rescinded within two years thereafter. In the event of any such rescission, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of the rescinded issuance in such manner and on such terms and conditions as may be required, and the Company shall be entitled to setoff against the amount of any such gain any amount owed to the Participant by the Company or any Affiliate.

7. Withholding of Taxes . The Company and its Affiliates shall have the right, in its discretion, to withhold cash from the Participant’s remuneration or deduct shares of Stock that would otherwise be distributed pursuant to this Award Agreement from any payment made under this Award Agreement in satisfaction of the federal, state, local or foreign income or other taxes required by law to be withheld with respect to such payment (or such higher amount that would not have an adverse tax effect). Shares of Stock tendered as payment of required tax withholding shall be valued at the fair market value of the Company’s Stock on the date such tax withholding obligation arises. It shall be a condition to the obligation of the Company to issue shares of Stock or other property, or any combination thereof, upon payment of the Award, that the Participant pay to the Company or an Affiliate, upon its demand, such amount as may be requested by the Company or the Affiliate for the purpose of satisfying any liability to withhold federal, state, local or foreign income or other taxes. If the amount requested is not paid, the Company may refuse to issue or pay shares of Stock or other property, or any combination thereof.

8. Miscellaneous .

(a) Compliance with Laws . If the Company, in its sole discretion, determines that the listing upon any securities exchange or registration or qualification under any federal, state or local law or any foreign law of any shares to be issued pursuant to an Award is necessary or desirable, issuance of such shares shall not be made until such listing, registration or qualification shall have been completed.

(b) Issuance of Stock . The issuance of shares of Stock from the conversion of PSUs may be made by crediting the shares of Stock to an account for the benefit of the Participant or by such other permissible manner chosen by the Company.

(c) Incorporation of Plan . The PSUs are subject to the Plan and any interpretations by the Committee under the Plan, which are hereby incorporated into this Award Agreement by reference and made a part hereof. By the execution of this Award Agreement, the Participant acknowledges that the Plan document and the Plan prospectus, as in effect on the date of this Agreement, have been made available to



Exhibit 10.6


the Participant for review. In the event of any conflict between the Plan and this Award Agreement, the Plan shall control.

(d) Administration, Interpretation, Etc . Any action taken or decision made by the Company, the Board or the Committee arising out of or in connection with the construction, administration, interpretation or effect of any provision of the Plan or this Award Agreement shall lie within its sole and absolute discretion, as the case may be, and shall be final, conclusive and binding on the Participant and all persons claiming under or through the Participant. By receipt of the PSUs or other benefit under the Plan, the Participant and each person claiming under or through the Participant shall be conclusively deemed to have indicated acceptance and ratification of, and consent to, any action taken under the Plan or this Award Agreement by the Company, the Board or the Committee.

(e) Amendment . This Award Agreement may be amended from time to time by the Committee, in its sole discretion, in any manner that the Committee deems necessary or appropriate; provided, however, that no such amendment shall adversely affect in a material manner any right of the Participant under the Award without the written consent of the Participant.

(f) Capital Changes and Adjustments . The PSUs shall be adjusted by the Committee at the same time as adjustments are made in accordance with Section 12 of the Plan in a manner similar to, and subject to, the same requirements under Section 12 of the Plan.

(g) No Right of Employment . Nothing contained herein shall confer upon the Participant any right to continued employment by the Company or any of its Affiliates or interfere in any way with the right of the Company or any of its Affiliates, which is hereby reserved, to terminate the employment of the Participant at any time for any reason whatsoever.

(h) No Stockholder Rights . Until the shares of Stock from the payment of the PSUs have been issued to the Participant, the Participant shall have no rights of a stockholder of the Company with respect to the shares of Stock underlying the PSUs, and in particular shall not be entitled to vote the underlying shares of Stock or to receive any dividends or dividend equivalents paid or made with respect to the shares of Stock underlying the PSUs.

(i) Notices . Any notices necessary or required to be given under this Award Agreement: (i) to the Company shall be sufficiently given if in writing, and personally delivered to the Secretary of the Company or mailed to its principal office, 105 Norton Street, P.O. Box 271, Newark, New York 14513; or (ii) to the Participant shall be sufficiently given if in writing, and personally delivered or mailed by registered or certified mail, return receipt requested, postage prepaid, to the last known address of the Participant, or to such other address as the Participant shall have specified in writing to the Company.

(j) Successors and Assigns . This Award Agreement shall bind and inure to the benefit of the Company and the successors and assigns of the Company and to the Participant and to the Participant’s heirs, executors, administrators, successors and assigns.

(k) Governing Law . All questions pertaining to the interpretation, validity, enforcement and performance of this Award Agreement shall be construed in accordance with, and be governed by, the laws of the State of New York, without giving effect to the choice of law principles thereof.

(l) Section 409A . The PSUs granted under this Award Agreement are intended to comply with the requirements of Section 409A and the Plan and this Award Agreement shall be interpreted and



Exhibit 10.6


administered in accordance with such intention. Notwithstanding the foregoing, the Company makes no representations that the PSUs comply with Section 409A, and in no event shall the Company or any Affiliate be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by a Participant on account of non-compliance with Section 409A. References to a Participant’s “termination of employment” and similar terms used in this Award Agreement mean, to the extent necessary to comply with Section 409A, the date that the Participant first incurs a “separation from service” within the meaning of Section 409A. Notwithstanding anything in this Award Agreement to the contrary, if at the time of the Participant’s separation from service, the Participant is a “specified employee” for purposes of Section 409A, and the payment of the PSUs under this Award Agreement as a result of such separation from service is required to be delayed by six months pursuant to Section 409A, then the Company will make such payment on the date that is the first day of the seventh month following the Participant’s separation from service.

(m) Participant Acknowledgement . By signing the Award Agreement, the Participant acknowledges that Participant has received a copy of the Plan, has had an opportunity to review the Plan and this Award Agreement in their entirety, understands all provisions of the Plan and this Award Agreement, and agrees to be bound by, and to comply with, all the terms and provisions of the Plan and this Award Agreement.

(n) Counterparts . This Award Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which shall constitute one and the same agreement.

*    *    *    *    *



Exhibit 10.6



IN WITNESS WHEREOF, the Company has caused this Award Agreement to be executed effective as of the Date of Grant set forth above.
 
IEC ELECTRONICS CORP.
 
 
 
 
By:
 
 
 
Chair, Compensation Committee
 
 
 
 
Date:
 


ACCEPTANCE
 
I, ___________________, hereby certify that I have read and fully understand the foregoing Award Agreement. I hereby execute this Award Agreement to indicate my acceptance of the PSUs and my intent to comply with the terms thereof.
 
 
 
 
Participant
 
 
 
 
 
Street Address
 
 
 
 
 
 
City
State
Zip Code
 
 
 
 
 
Date:
 



Exhibit 10.6




EXHIBIT A

PERFORMANCE GOAL AND AWARD DETERMINATION
[________]



Exhibit 31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
I, Jeffrey T. Schlarbaum , certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q for the three and nine months ended June 28, 2019 of IEC Electronics Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: August 7, 2019
By:
/s/ Jeffrey T. Schlarbaum
 
 
Jeffrey T. Schlarbaum
 
 
President & Chief Executive Officer
 
 
(On behalf of the Registrant and as Principal Executive Officer and Principal Financial Officer)
 



Exhibit 31.2


Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
I, Thomas L. Barbato , certify that:
 
1.
I have reviewed this Quarterly Report on Form 10-Q for the three and nine months ended June 28, 2019 of IEC Electronics Corp.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 
Dated: August 7, 2019
 
/s/ Thomas L. Barbato
 
 
Thomas L. Barbato
 
 
Senior Vice President and Chief Financial Officer
 
 
(On behalf of the Registrant and as Principal Financial and Accounting Officer)
 



Exhibit 32.1


Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the the Quarterly Report of IEC Electronics Corp. (the "Company") on Form 10-Q for the three and nine months ended June 28, 2019 as filed with the Securities and Exchange Commission on the day hereof (the "Report"), I, Jeffrey T. Schlarbaum , President & Chief Executive Officer of the Company and I, Thomas L. Barbato , Senior Vice President and Chief Financial Officer , certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 


Dated: August 7, 2019
 
/s/ Jeffrey T. Schlarbaum
 
 
Jeffrey T. Schlarbaum
 
 
President & Chief Executive Officer
 
 
(On behalf of the Registrant and as Principal Executive Officer and Principal Financial Officer)
 
Dated: August 7, 2019
 
/s/ Thomas L. Barbato
 
 
Thomas L. Barbato
 
 
Senior Vice President and Chief Financial Officer
 
 
(On behalf of the Registrant and as Principal Financial and Accounting Officer)